<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27240531</article-id>
<article-id pub-id-type="pmc">5508252</article-id>
<article-id pub-id-type="pii">mp201684</article-id>
<article-id pub-id-type="doi">10.1038/mp.2016.84</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chromosomal contacts connect loci associated with autism, BMI and head
circumference phenotypes</article-title>
<alt-title alt-title-type="running">Chromosomal contacts of 16p11.2 CNVs</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Loviglio</surname>
<given-names>M N</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="author-notes" rid="note1">
<sup>24</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leleu</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="author-notes" rid="note1">
<sup>24</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Männik</surname>
<given-names>K</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Passeggeri</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giannuzzi</surname>
<given-names>G</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van der Werf</surname>
<given-names>I</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Waszak</surname>
<given-names>S M</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zazhytska</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roberts-Caldeira</surname>
<given-names>I</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gheldof</surname>
<given-names>N</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Migliavacca</surname>
<given-names>E</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alfaiz</surname>
<given-names>A A</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hippolyte</surname>
<given-names>L</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maillard</surname>
<given-names>A M</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<collab>2p15 Consortium<contrib-group><contrib contrib-type="author"><name><surname>Loviglio</surname><given-names>Maria Nicla</given-names></name></contrib><contrib contrib-type="author"><name><surname>Männik</surname><given-names>Katrin</given-names></name></contrib><contrib contrib-type="author"><name><surname>van der Werf</surname><given-names>Ilse</given-names></name></contrib><contrib contrib-type="author"><name><surname>Giannuzzi</surname><given-names>Giuliana</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zazhytska</surname><given-names>Marianna</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gheldof</surname><given-names>Nele</given-names></name></contrib><contrib contrib-type="author"><name><surname>Migliavacca</surname><given-names>Eugenia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Alfaiz</surname><given-names>Ali A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Roberts-Caldeira</surname><given-names>Inês</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hippolyte</surname><given-names>Loyse</given-names></name></contrib><contrib contrib-type="author"><name><surname>Maillard</surname><given-names>Anne M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ferrarini</surname><given-names>Alessandra</given-names></name></contrib><contrib contrib-type="author"><name><surname>Butschi</surname><given-names>Florence Niel</given-names></name></contrib><contrib contrib-type="author"><name><surname>Conrad</surname><given-names>Bernard</given-names></name></contrib><contrib contrib-type="author"><name><surname>Addor</surname><given-names>Marie-Claude</given-names></name></contrib><contrib contrib-type="author"><name><surname>Belfiore</surname><given-names>Marco</given-names></name></contrib><contrib contrib-type="author"><name><surname>Roetzer</surname><given-names>Katharina</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dijck</surname><given-names>Anke Van</given-names></name></contrib><contrib contrib-type="author"><name><surname>Blaumeiser</surname><given-names>Bettina</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kooy</surname><given-names>Frank</given-names></name></contrib><contrib contrib-type="author"><name><surname>Roelens</surname><given-names>Filip</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dheedene</surname><given-names>Annelies</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chiaie</surname><given-names>Barbara Delle</given-names></name></contrib><contrib contrib-type="author"><name><surname>Menten</surname><given-names>Björn</given-names></name></contrib><contrib contrib-type="author"><name><surname>Oostra</surname><given-names>Ann</given-names></name></contrib><contrib contrib-type="author"><name><surname>Caberg</surname><given-names>Jean-Hubert</given-names></name></contrib><contrib contrib-type="author"><name><surname>Carter</surname><given-names>Melissa</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kellam</surname><given-names>Barbara</given-names></name></contrib><contrib contrib-type="author"><name><surname>Stavropoulos</surname><given-names>Dimitri J</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marshall</surname><given-names>Christian</given-names></name></contrib><contrib contrib-type="author"><name><surname>Scherer</surname><given-names>Stephen W</given-names></name></contrib><contrib contrib-type="author"><name><surname>Weksberg</surname><given-names>Rosanna</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cytrynbaum</surname><given-names>Cheryl</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bassett</surname><given-names>Anne</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lowther</surname><given-names>Chelsea</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gillis</surname><given-names>Jane</given-names></name></contrib><contrib contrib-type="author"><name><surname>MacKay</surname><given-names>Sara</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bache</surname><given-names>Iben</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ousager</surname><given-names>Lilian B</given-names></name></contrib><contrib contrib-type="author"><name><surname>Smerdel</surname><given-names>Maja Patricia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Graakjaer</surname><given-names>Jesper</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kjaergaard</surname><given-names>Susanne</given-names></name></contrib><contrib contrib-type="author"><name><surname>Metspalu</surname><given-names>Andres</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mathieu</surname><given-names>Michele</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bonneau</surname><given-names>Dominique</given-names></name></contrib><contrib contrib-type="author"><name><surname>Guichet</surname><given-names>Agnes</given-names></name></contrib><contrib contrib-type="author"><name><surname>Parent</surname><given-names>Philippe</given-names></name></contrib><contrib contrib-type="author"><name><surname>Férec</surname><given-names>Claude</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gerard</surname><given-names>Marion</given-names></name></contrib><contrib contrib-type="author"><name><surname>Plessis</surname><given-names>Ghislaine</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lespinasse</surname><given-names>James</given-names></name></contrib><contrib contrib-type="author"><name><surname>Masurel</surname><given-names>Alice</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marle</surname><given-names>Nathalie</given-names></name></contrib><contrib contrib-type="author"><name><surname>Faivre</surname><given-names>Laurence</given-names></name></contrib><contrib contrib-type="author"><name><surname>Callier</surname><given-names>Patrick</given-names></name></contrib><contrib contrib-type="author"><name><surname>Layet</surname><given-names>Valerie</given-names></name></contrib><contrib contrib-type="author"><name><surname>Meur</surname><given-names>Nathalie Le</given-names></name></contrib><contrib contrib-type="author"><name><surname>Le Goff</surname><given-names>Céline</given-names></name></contrib><contrib contrib-type="author"><name><surname>Duban-Bedu</surname><given-names>Bénédicte</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sukno</surname><given-names>Sylvie</given-names></name></contrib><contrib contrib-type="author"><name><surname>Boute</surname><given-names>Odile</given-names></name></contrib><contrib contrib-type="author"><name><surname>Andrieux</surname><given-names>Joris</given-names></name></contrib><contrib contrib-type="author"><name><surname>Blanchet</surname><given-names>Patricia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Geneviève</surname><given-names>David</given-names></name></contrib><contrib contrib-type="author"><name><surname>Puechberty</surname><given-names>Jacques</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schneider</surname><given-names>Anouck</given-names></name></contrib><contrib contrib-type="author"><name><surname>Leheup</surname><given-names>Bruno</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jonveaux</surname><given-names>Philippe</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mercier</surname><given-names>Sandra</given-names></name></contrib><contrib contrib-type="author"><name><surname>David</surname><given-names>Albert</given-names></name></contrib><contrib contrib-type="author"><name><surname>Le Caignec</surname><given-names>Cédric</given-names></name></contrib><contrib contrib-type="author"><name><surname>de Pontual</surname><given-names>Loic</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pipiras</surname><given-names>Eva</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jacquette</surname><given-names>Aurelia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Keren</surname><given-names>Boris</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gilbert-Dussardier</surname><given-names>Brigitte</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bilan</surname><given-names>Frederic</given-names></name></contrib><contrib contrib-type="author"><name><surname>Goldenberg</surname><given-names>Alice</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chambon</surname><given-names>Pascal</given-names></name></contrib><contrib contrib-type="author"><name><surname>Toutain</surname><given-names>Annick</given-names></name></contrib><contrib contrib-type="author"><name><surname>Till</surname><given-names>Marianne</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sanlaville</surname><given-names>Damien</given-names></name></contrib><contrib contrib-type="author"><name><surname>Leube</surname><given-names>Barbara</given-names></name></contrib><contrib contrib-type="author"><name><surname>Royer-Pokora</surname><given-names>Brigitte</given-names></name></contrib><contrib contrib-type="author"><name><surname>Grabe</surname><given-names>Hans Jörgen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schmidt</surname><given-names>Carsten Oliver</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schurmann</surname><given-names>Claudia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Homuth</surname><given-names>Georg</given-names></name></contrib><contrib contrib-type="author"><name><surname>Thorleifsson</surname><given-names>Gudmar</given-names></name></contrib><contrib contrib-type="author"><name><surname>Thorsteinsdottir</surname><given-names>Unnur</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bernardini</surname><given-names>Laura</given-names></name></contrib><contrib contrib-type="author"><name><surname>Novelli</surname><given-names>Antonio</given-names></name></contrib><contrib contrib-type="author"><name><surname>Micale</surname><given-names>Lucia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Merla</surname><given-names>Giuseppe</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zollino</surname><given-names>Marcella</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mari</surname><given-names>Francesca</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rizzo</surname><given-names>Caterina Lo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Renieri</surname><given-names>Alessandra</given-names></name></contrib><contrib contrib-type="author"><name><surname>Silengo</surname><given-names>Margherita</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vulto-van Silfhout</surname><given-names>Anneke T</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schouten</surname><given-names>Meyke</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pfundt</surname><given-names>Rolph</given-names></name></contrib><contrib contrib-type="author"><name><surname>de Leeuw</surname><given-names>Nicole</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vansenne</surname><given-names>Fleur</given-names></name></contrib><contrib contrib-type="author"><name><surname>Maas</surname><given-names>Saskia M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Barge-Schaapveld</surname><given-names>Daniela QCM</given-names></name></contrib><contrib contrib-type="author"><name><surname>Knegt</surname><given-names>Alida C</given-names></name></contrib><contrib contrib-type="author"><name><surname>Stadheim</surname><given-names>Barbro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rodningen</surname><given-names>Olaug</given-names></name></contrib><contrib contrib-type="author"><name><surname>Houge</surname><given-names>Gunnar</given-names></name></contrib><contrib contrib-type="author"><name><surname>Price</surname><given-names>Sue</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hawkes</surname><given-names>Lara</given-names></name></contrib><contrib contrib-type="author"><name><surname>Campbell</surname><given-names>Carolyn</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kini</surname><given-names>Usha</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vogt</surname><given-names>Julie</given-names></name></contrib><contrib contrib-type="author"><name><surname>Walters</surname><given-names>Robin</given-names></name></contrib><contrib contrib-type="author"><name><surname>Blakemore</surname><given-names>Alexandra</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gusella</surname><given-names>James F</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Yiping</given-names></name></contrib><contrib contrib-type="author"><name><surname>Scott</surname><given-names>Daryl</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bacino</surname><given-names>Carlos A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tsuchiya</surname><given-names>Karen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ladda</surname><given-names>Roger</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sell</surname><given-names>Susan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Asamoah</surname><given-names>Alexander</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hamati</surname><given-names>Aline I</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rosenfeld</surname><given-names>Jill A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shaffer</surname><given-names>Lisa G</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mitchell</surname><given-names>Elyse</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hodge</surname><given-names>Jennelle C</given-names></name></contrib><contrib contrib-type="author"><name><surname>Beckmann</surname><given-names>Jacques S</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jacquemont</surname><given-names>Sébastien</given-names></name></contrib><contrib contrib-type="author"><name><surname>Reymond</surname><given-names>Alexandre</given-names></name></contrib></contrib-group></collab>
<xref ref-type="author-notes" rid="d33e235">*</xref>
<xref ref-type="author-notes" rid="note2">
<sup>25</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<collab>16p11.2 Consortium<contrib-group><contrib contrib-type="author"><name><surname>Reymond</surname><given-names>Alexandre</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ewans</surname><given-names>Lisa J</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mowat</surname><given-names>David</given-names></name></contrib><contrib contrib-type="author"><name><surname>Walker</surname><given-names>Jan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Amor</surname><given-names>David J</given-names></name></contrib><contrib contrib-type="author"><name><surname>Esch</surname><given-names>Hilde Van</given-names></name></contrib><contrib contrib-type="author"><name><surname>Leroy</surname><given-names>Patricia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Caberg</surname><given-names>Jean-Hubert</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bamforth</surname><given-names>John-Steven</given-names></name></contrib><contrib contrib-type="author"><name><surname>Babu</surname><given-names>Deepti</given-names></name></contrib><contrib contrib-type="author"><name><surname>Till</surname><given-names>Marianne</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sanlaville</surname><given-names>Damien</given-names></name></contrib><contrib contrib-type="author"><name><surname>Geneviève</surname><given-names>David</given-names></name></contrib><contrib contrib-type="author"><name><surname>Puechberty</surname><given-names>Jacques</given-names></name></contrib><contrib contrib-type="author"><name><surname>Isidor</surname><given-names>Bertrand</given-names></name></contrib><contrib contrib-type="author"><name><surname>DiDonato</surname><given-names>Nataliya</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hackmann</surname><given-names>Karl</given-names></name></contrib><contrib contrib-type="author"><name><surname>Passeggeri</surname><given-names>Marzia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Haeringen</surname><given-names>Arie van</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rosenfeld</surname><given-names>Jill A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shaffer</surname><given-names>Lisa G</given-names></name></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Rosemarie</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ellingwood</surname><given-names>Sara</given-names></name></contrib><contrib contrib-type="author"><name><surname>Farber</surname><given-names>Darren M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Puri</surname><given-names>Vinay</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zadeh</surname><given-names>Neda</given-names></name></contrib><contrib contrib-type="author"><name><surname>Weaver</surname><given-names>David D</given-names></name></contrib><contrib contrib-type="author"><name><surname>Miller</surname><given-names>Mandy</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wilks</surname><given-names>Timothy</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jorgez</surname><given-names>Carolina J</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lafayette</surname><given-names>DeeDee</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jacquemont</surname><given-names>Sébastien</given-names></name></contrib></contrib-group></collab>
<xref ref-type="author-notes" rid="d33e1192">*</xref>
<xref ref-type="author-notes" rid="note3">
<sup>26</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van Dijck</surname>
<given-names>A</given-names>
</name>
<xref ref-type="aff" rid="aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kooy</surname>
<given-names>R F</given-names>
</name>
<xref ref-type="aff" rid="aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanlaville</surname>
<given-names>D</given-names>
</name>
<xref ref-type="aff" rid="aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>J A</given-names>
</name>
<xref ref-type="aff" rid="aff9">9</xref>
<xref ref-type="aff" rid="aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shaffer</surname>
<given-names>L G</given-names>
</name>
<xref ref-type="aff" rid="aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Andrieux</surname>
<given-names>J</given-names>
</name>
<xref ref-type="aff" rid="aff12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marshall</surname>
<given-names>C</given-names>
</name>
<xref ref-type="aff" rid="aff13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scherer</surname>
<given-names>S W</given-names>
</name>
<xref ref-type="aff" rid="aff14">14</xref>
<xref ref-type="aff" rid="aff15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
<xref ref-type="aff" rid="aff16">16</xref>
<xref ref-type="aff" rid="aff17">17</xref>
<xref ref-type="aff" rid="aff18">18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gusella</surname>
<given-names>J F</given-names>
</name>
<xref ref-type="aff" rid="aff19">19</xref>
<xref ref-type="aff" rid="aff20">20</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thorsteinsdottir</surname>
<given-names>U</given-names>
</name>
<xref ref-type="aff" rid="aff21">21</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thorleifsson</surname>
<given-names>G</given-names>
</name>
<xref ref-type="aff" rid="aff21">21</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dermitzakis</surname>
<given-names>E T</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff22">22</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deplancke</surname>
<given-names>B</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Beckmann</surname>
<given-names>J S</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="aff" rid="aff23">23</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rougemont</surname>
<given-names>J</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jacquemont</surname>
<given-names>S</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="author-notes" rid="note4">
<sup>27</sup>
</xref>
<xref ref-type="author-notes" rid="note5">
<sup>28</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reymond</surname>
<given-names>A</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
<xref ref-type="author-notes" rid="note5">
<sup>28</sup>
</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Center for Integrative Genomics,
University of Lausanne</institution>, Lausanne, <country>Switzerland</country></aff>
<aff id="aff2"><label>2</label><institution>Swiss Institute of Bioinformatics
(SIB)</institution>, Lausanne, <country>Switzerland</country></aff>
<aff id="aff3"><label>3</label><institution>School of Life Sciences, EPFL (Ecole
Polytechnique Fédérale de Lausanne)</institution>, Lausanne,
<country>Switzerland</country></aff>
<aff id="aff4"><label>4</label><institution>Estonian Genome Center, University of
Tartu</institution>, Tartu, <country>Estonia</country></aff>
<aff id="aff5"><label>5</label><institution>Service of Medical Genetics, Lausanne
University Hospital (CHUV)</institution>, Lausanne,
<country>Switzerland</country></aff>
<aff id="aff6"><label>6</label><institution>Genome Biology Unit, European Molecular
Biology Laboratory (EMBL)</institution>, Heidelberg, <country>Germany</country></aff>
<aff id="aff7"><label>7</label><institution>Department of Medical Genetics,
University of Antwerp</institution>, Antwerp, <country>Belgium</country></aff>
<aff id="aff8"><label>8</label><institution>Service de Génétique,
Hôpital Femme Mère Enfant, Centre de Biologie et Pathologie Est,
Hospices Civils de Lyon, CRNL, CNRS UMR5292, INSERM U1028, Université
Claude Bernard Lyon I</institution>, Bron, <country>France</country></aff>
<aff id="aff9"><label>9</label><institution>Signature Genomic Laboratories,
PerkinElmer, Inc.</institution>, Spokane, WA,
<country>USA</country></aff>
<aff id="aff10"><label>10</label><institution>Department of Molecular &amp; Human
Genetics, Baylor College of Medicine</institution>, Houston,
TX, <country>USA</country></aff>
<aff id="aff11"><label>11</label><institution>Paw Print Genetics, Genetic Veterinary
Sciences, Inc.</institution>, Spokane, WA, <country>USA</country></aff>
<aff id="aff12"><label>12</label><institution>Institut de Génétique
Médicale, CHRU de Lille - Hôpital Jeanne de Flandre</institution>,
Lille, <country>France</country></aff>
<aff id="aff13"><label>13</label><institution>Genome Diagnostics, Department of
Paediatric Laboratory Medicine, The Hospital for Sick Children</institution>,
Toronto, ON, <country>USA</country></aff>
<aff id="aff14"><label>14</label><institution>The Centre for Applied Genomics, The
Hospital for Sick Children</institution>, Toronto, ON,
<country>USA</country></aff>
<aff id="aff15"><label>15</label><institution>McLaughlin Centre and Department of
Molecular Genetics, University of Toronto</institution>, Toronto,
ON, <country>USA</country></aff>
<aff id="aff16"><label>16</label><institution>Department of Pathology, Harvard
Medical School</institution>, Boston, MA, <country>USA</country></aff>
<aff id="aff17"><label>17</label><institution>Department of Laboratory Medicine,
Boston Children's Hospital</institution>, Boston, MA,
<country>USA</country></aff>
<aff id="aff18"><label>18</label><institution>Shanghai Jiaotong University, School of
Medicine</institution>, Shanghai, <country>China</country></aff>
<aff id="aff19"><label>19</label><institution>Center for Human Genetic Research,
Massachusetts General Hospital</institution>, Boston, MA,
<country>USA</country></aff>
<aff id="aff20"><label>20</label><institution>Departments of Genetics and Neurology,
Harvard Medical School</institution>, Boston, MA,
<country>USA</country></aff>
<aff id="aff21"><label>21</label><institution>deCODE Genetics, Amgen</institution>,
Reykjavik, <country>Iceland</country></aff>
<aff id="aff22"><label>22</label><institution>Department of Genetic Medicine and
Development, University of Geneva Medical School</institution>, Geneva,
<country>Switzerland</country></aff>
<aff id="aff23"><label>23</label><institution>Department of Medical Genetics,
University of Lausanne</institution>, Lausanne, <country>Switzerland</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Center for Integrative Genomics, University of
Lausanne</institution>, Genopode Building, Lausanne
CH-1015, <country>Switzerland</country>. E-mail: <email>alexandre.reymond@unil.ch</email></corresp>
<fn fn-type="present-address" id="note1">
<label>24</label>
<p>Co-first authors.</p>
</fn>
<fn fn-type="present-address" id="note2">
<label>25</label>
<p>The list of the 16p11.2 Consortium members is specified before conflict of
interest, while their affiliations are detailed in <xref ref-type="supplementary-material" rid="sup1">Supplemental Data</xref>.</p>
</fn>
<fn fn-type="present-address" id="note3">
<label>26</label>
<p>The list of the 2p15 Consortium members is specified before conflict of interest,
while their affiliations are detailed in <xref ref-type="supplementary-material" rid="sup1">Supplemental
Data</xref>.</p>
</fn>
<fn fn-type="present-address" id="note4">
<label>27</label>
<p>Current address: CHU Sainte Justine, University of Montreal, Montreal, QC,
Canada.</p>
</fn>
<fn fn-type="present-address" id="note5">
<label>28</label>
<p>Co-senior authors.</p>
</fn>
<fn fn-type="author-notes" id="d33e235">
<label>*</label>
<p><bold>16p11.2 Consortium members</bold>
Maria Nicla Loviglio, Katrin
Männik, Ilse van der Werf, Giuliana Giannuzzi, Marianna Zazhytska, Nele
Gheldof, Eugenia Migliavacca, Ali A Alfaiz, Inês Roberts-Caldeira, Loyse
Hippolyte, Anne M Maillard, Alessandra Ferrarini, Florence Niel Butschi, Bernard
Conrad, Marie-Claude Addor, Marco Belfiore, Katharina Roetzer, Anke Van Dijck,
Bettina Blaumeiser, Frank Kooy, Filip Roelens, Annelies Dheedene, Barbara Delle
Chiaie, Björn Menten, Ann Oostra, Jean-Hubert Caberg, Melissa Carter, Barbara
Kellam, Dimitri J Stavropoulos, Christian Marshall, Stephen W Scherer, Rosanna
Weksberg, Cheryl Cytrynbaum, Anne Bassett, Chelsea Lowther, Jane Gillis, Sara
MacKay, Iben Bache, Lilian B Ousager, Maja Patricia Smerdel, Jesper Graakjaer,
Susanne Kjaergaard, Andres Metspalu, Michele Mathieu, Dominique Bonneau, Agnes
Guichet, Philippe Parent, Claude Férec, Marion Gerard, Ghislaine Plessis,
James Lespinasse, Alice Masurel, Nathalie Marle, Laurence Faivre, Patrick Callier,
Valerie Layet, Nathalie Le Meur, Céline Le Goff, Bénédicte
Duban-Bedu, Sylvie Sukno, Odile Boute, Joris Andrieux, Patricia Blanchet, David
Geneviève, Jacques Puechberty, Anouck Schneider, Bruno Leheup, Philippe
Jonveaux, Sandra Mercier, Albert David, Cédric Le Caignec, Loic de Pontual,
Eva Pipiras, Aurelia Jacquette, Boris Keren, Brigitte Gilbert-Dussardier, Frederic
Bilan, Alice Goldenberg, Pascal Chambon, Annick Toutain, Marianne Till, Damien
Sanlaville, Barbara Leube, Brigitte Royer-Pokora, Hans Jörgen Grabe, Carsten
Oliver Schmidt, Claudia Schurmann, Georg Homuth, Gudmar Thorleifsson, Unnur
Thorsteinsdottir, Laura Bernardini, Antonio Novelli, Lucia Micale, Giuseppe Merla,
Marcella Zollino, Francesca Mari, Caterina Lo Rizzo, Alessandra Renieri,
Margherita Silengo, Anneke T Vulto-van Silfhout, Meyke Schouten, Rolph Pfundt,
Nicole de Leeuw, Fleur Vansenne, Saskia M Maas, Daniela QCM Barge-Schaapveld,
Alida C Knegt, Barbro Stadheim, Olaug Rodningen, Gunnar Houge, Sue Price, Lara
Hawkes, Carolyn Campbell, Usha Kini, Julie Vogt, Robin Walters, Alexandra
Blakemore, James F Gusella, Yiping Shen, Daryl Scott, Carlos A Bacino, Karen
Tsuchiya, Roger Ladda, Susan Sell, Alexander Asamoah, Aline I Hamati, Jill A
Rosenfeld, Lisa G Shaffer, Elyse Mitchell, Jennelle C Hodge, Jacques S Beckmann,
Sébastien Jacquemont, Alexandre Reymond. The affiliations and email
addresses of the members of the 16p11.2 Consortium are listed in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S36</xref>.</p>
</fn>
<fn fn-type="author-notes" id="d33e1192">
<label>*</label>
<p><bold>2p15 Consortium members</bold>
Alexandre Reymond, Lisa J Ewans,
David Mowat, Jan Walker, David J Amor, Hilde Van Esch, Patricia Leroy, Jean-Hubert
Caberg, John-Steven Bamforth, Deepti Babu, Marianne Till, Damien Sanlaville, David
Geneviève, Jacques Puechberty, Bertrand Isidor, Nataliya DiDonato, Karl
Hackmann, Marzia Passeggeri, Arie van Haeringen, Jill A Rosenfeld, Lisa G Shaffer,
Rosemarie Smith, Sara Ellingwood, Darren M Farber, Vinay Puri, Neda Zadeh, David D
Weaver, Mandy Miller, Timothy Wilks, Carolina J Jorgez, DeeDee Lafayette,
Sébastien Jacquemont. The affiliations and email addresses of the members
of the 2p15 Consortium are listed in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table
S37</xref>.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>05</month>
<year>2016</year>
</pub-date>
<volume>22</volume>
<issue>6</issue>
<fpage>836</fpage>
<lpage>849</lpage>
<history>
<date date-type="received">
<day>04</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>18</day>
<month>03</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>04</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Macmillan Publishers Limited</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Macmillan Publishers Limited</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--author-paid-->
<license-p>This work is licensed under a Creative Commons
Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other
third party material in this article are included in the article’s Creative
Commons license, unless indicated otherwise in the credit line; if the material is
not included under the Creative Commons license, users will need to obtain permission
from the license holder to reproduce the material. To view a copy of this license,
visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/">http://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link></license-p>
</license>
</permissions>
<abstract>
<p>Copy number variants (CNVs) are major contributors to genomic imbalance disorders.
Phenotyping of 137 unrelated deletion and reciprocal duplication carriers of the
distal 16p11.2 220 kb BP2-BP3 interval showed that these rearrangements are
associated with autism spectrum disorders and mirror phenotypes of
obesity/underweight and macrocephaly/microcephaly. Such phenotypes were
previously associated with rearrangements of the non-overlapping proximal 16p11.2
600 kb BP4-BP5 interval. These two CNV-prone regions at 16p11.2 are
reciprocally engaged in complex chromatin looping, as successfully confirmed by
4C-seq, fluorescence <italic>in situ</italic> hybridization and Hi-C, as well as coordinated
expression and regulation of encompassed genes. We observed that genes differentially
expressed in 16p11.2 BP4-BP5 CNV carriers are concomitantly modified in their
chromatin interactions, suggesting that disruption of chromatin interplays could
participate in the observed phenotypes. We also identified <italic>cis</italic>- and
<italic>trans</italic>-acting chromatin contacts to other genomic regions previously
associated with analogous phenotypes. For example, we uncovered that individuals with
reciprocal rearrangements of the <italic>trans</italic>-contacted 2p15 locus similarly
display mirror phenotypes on head circumference and weight. Our results indicate that
chromosomal contacts’ maps could uncover functionally and clinically related
genes.</p>
</abstract>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Long-range chromatin contacts that bring genes and regulatory sequences in close
proximity are necessary for co-transcription of biologically related and
developmentally co-regulated genes.<sup><xref ref-type="bibr" rid="bib1">1</xref>, <xref ref-type="bibr" rid="bib2">2</xref></sup> Correspondingly, genomic structural changes were
associated with disruption of the organization of chromatin compartments by shifting
regulatory elements between domains and/or modifying domain boundaries, which
resulted in ectopic interactions, gene misexpression and disease.<sup><xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib4">4</xref></sup> In the last 15
million years the 16p11.2–12.2 region rapidly integrated segmental duplications
contributing to profound modifications of these chromosomal bands in
hominoids.<sup><xref ref-type="bibr" rid="bib5">5</xref>, <xref ref-type="bibr" rid="bib6">6</xref></sup> It allowed the emergence of new transcripts<sup><xref ref-type="bibr" rid="bib7">7</xref></sup> and placed the whole region at risk for various
recurrent rearrangements<sup><xref ref-type="bibr" rid="bib8">8</xref>, <xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib10">10</xref></sup> through non-allelic
homologous recombination<sup><xref ref-type="bibr" rid="bib11">11</xref></sup> (<xref ref-type="fig" rid="fig1">Figure 1</xref>). These rearrangements include a recurrent
interstitial deletion of ~600 kb defined by 16p11.2 breakpoints 4–5
(BP4-BP5; OMIM#611913), which encompasses 28 ‘unique’ genes and four
genes with multiple copies<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> (<xref ref-type="fig" rid="fig1">Figure 1</xref>). With a population prevalence of ~0.05% this
variant is one of the most frequent known etiologies of autism spectrum disorder
(ASD).<sup><xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib13">13</xref>,
<xref ref-type="bibr" rid="bib14">14</xref>, <xref ref-type="bibr" rid="bib15">15</xref></sup> It
impacts adaptive behavior and language skills and predisposes to a highly penetrant
form of obesity and macrocephaly.<sup><xref ref-type="bibr" rid="bib15">15</xref>, <xref ref-type="bibr" rid="bib16">16</xref>, <xref ref-type="bibr" rid="bib17">17</xref>, <xref ref-type="bibr" rid="bib18">18</xref>, <xref ref-type="bibr" rid="bib19">19</xref></sup> A mirror
phenotype is observed in carriers of the reciprocal duplication (OMIM#614671),
who present a high risk of schizophrenia (SCZ), Rolandic epilepsy, being underweight
and microcephalic.<sup><xref ref-type="bibr" rid="bib18">18</xref>, <xref ref-type="bibr" rid="bib19">19</xref>, <xref ref-type="bibr" rid="bib20">20</xref>, <xref ref-type="bibr" rid="bib21">21</xref>, <xref ref-type="bibr" rid="bib22">22</xref></sup> Case series have
reported variable expressivity; systematic phenotyping showed that deletion and
duplication lead to an average IQ decrease of 26 and 16 points in proband compared
with non-carrier family members.<sup><xref ref-type="bibr" rid="bib15">15</xref>, <xref ref-type="bibr" rid="bib23">23</xref></sup> Correspondingly, the phenotypes of carriers
identified in unselected populations are reminiscent of those described for carriers
of 16p11.2 rearrangements ascertained in clinical cohorts.<sup><xref ref-type="bibr" rid="bib24">24</xref></sup> Deletions and duplications show a mirroring impact on brain
volume and specific cortico-striatal structures implicated in reward, language and
social cognition.<sup><xref ref-type="bibr" rid="bib25">25</xref></sup> Changes in copy numbers
of this interval are associated with significant modifications of the mRNA levels of
ciliopathy and ASD-associated genes in humans and mice.<sup><xref ref-type="bibr" rid="bib12">12</xref>, <xref ref-type="bibr" rid="bib26">26</xref></sup> Correspondingly, mouse
models engineered to have three copies of the 7qF3 orthologous region showed reduced
cilia length in the CA1 hippocampal region, whereas modulation of the expression of
ciliopathy-associated genes rescued phenotypes induced by <italic>KCTD13</italic>
(MIM#608947) under- and overexpression,<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> one of the key drivers of the 16p11.2 600 kb BP4-BP5
CNV genomic-interval associated traits.<sup><xref ref-type="bibr" rid="bib27">27</xref></sup>
Distal to BP4-BP5, the deletion of 16p11.2 220 kb BP2-BP3 interval was
similarly associated with obesity, developmental delay, intellectual disability and
SCZ.<sup><xref ref-type="bibr" rid="bib16">16</xref>, <xref ref-type="bibr" rid="bib28">28</xref>,
<xref ref-type="bibr" rid="bib29">29</xref>, <xref ref-type="bibr" rid="bib30">30</xref>, <xref ref-type="bibr" rid="bib31">31</xref>, <xref ref-type="bibr" rid="bib32">32</xref>, <xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib34">34</xref>, <xref ref-type="bibr" rid="bib35">35</xref></sup> However, detailed data about the phenotypes
associated with the reciprocal duplication are still lacking.</p>
<p>We hypothesized that copy number modification of the 16p11.2 600 kb BP4-BP5
interval alters the three-dimensional positioning of these genes resulting in
expression alterations of pathways involved in its phenotypic manifestation. We used
chromatin conformation capture to explore the chromosome-wide effects of the 16p11.2
600 kb BP4-BP5 structural rearrangements on chromatin structure and assessed
how these underlay the associated phenotypes. This region engages in multi-gene
complex structures that are disrupted when its copy number changes. The implicated
genes are known to be linked to 16p11.2-associated phenotypes, such as primary cilium
alteration, energy imbalance, head circumference (HC) and ASD. We also demonstrate
that our approach could be used to identify additional loci, whose copy number
changes are associated with strikingly similar phenotypic manifestations.</p>
</sec>
<sec>
<title>Materials and methods</title>
<sec>
<title>Recruitment and phenotyping of patients</title>
<p>The institutional review board of the University of Lausanne, Switzerland approved
this study. Participants were enrolled in the study after signing an informed
consent form and being clinically assessed by their respective physicians. For the
data collected through questionnaires, information was gathered retrospectively
and anonymously by physicians who had ordered chromosomal microarray analyses
performed for clinical purposes only. Consequently, research-based informed
consent was not required by the institutional review board of the University of
Lausanne, which granted an exemption for this part of the data collection. Overall
cognitive functioning was assessed as published.<sup><xref ref-type="bibr" rid="bib15">15</xref></sup></p>
<p>To better assess the phenotypic features associated with the 16p11.2 220 kb
BP2-BP3 rearrangements, we recruited and phenotyped 110 and 57 carriers of the
220 kb BP2-BP3 deletion (OMIM#613444) and duplication from 88 and 49
families, respectively (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1</xref>).
Whereas these structural variants were previously reported to be among the CNVs
most frequently harboring a possibly deleterious second genetic lesion (29 and
13% of the time, respectively),<sup><xref ref-type="bibr" rid="bib32">32</xref></sup>
we do not confirm such propensity. Indeed, second-site structural variants were
identified in ‘only’ 7% (6/88) and 4% (2/49) of
the enrolled BP2-BP3 deletion and duplication carrier probands, respectively.
Deleterious CNVs were defined as: (i) known recurrent genomic disorder, (ii) CNV
encompassing published critical genomic region or disrupting a gene that is a
known etiology of neurodevelopmental disorders or (iii) &gt;500 kb CNV with
AF&lt;0.001. We compared available data on weight, height, body mass index (BMI)
and HC for 77 and 39 unrelated deletion and duplication carriers, respectively
(including published cases). The mean age of this group of patients was 16 years
(range 0.42–78 years, with 34 cases older than 18 years). The prevalence of
the 16p11.2 deletion and duplication were inferred from six European
population-based genome-wide association studies cohorts, sets of chromosomal
microarray-genotyped control individuals and clinical cohorts.<sup><xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib30">30</xref>, <xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib35">35</xref>, <xref ref-type="bibr" rid="bib36">36</xref>, <xref ref-type="bibr" rid="bib37">37</xref>, <xref ref-type="bibr" rid="bib38">38</xref>, <xref ref-type="bibr" rid="bib39">39</xref></sup> CNV
analyses were carried out as described in Jacquemont <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib18">18</xref></sup></p>
<p>We similarly enrolled 26 and 9 unrelated carriers of 2p15 deletions and
duplications, including 12 deletion cases from the literature.<sup><xref ref-type="bibr" rid="bib40">40</xref>, <xref ref-type="bibr" rid="bib41">41</xref>, <xref ref-type="bibr" rid="bib42">42</xref>, <xref ref-type="bibr" rid="bib43">43</xref>, <xref ref-type="bibr" rid="bib44">44</xref>, <xref ref-type="bibr" rid="bib45">45</xref>, <xref ref-type="bibr" rid="bib46">46</xref>, <xref ref-type="bibr" rid="bib47">47</xref>, <xref ref-type="bibr" rid="bib48">48</xref>, <xref ref-type="bibr" rid="bib49">49</xref></sup> The
Signature Genomics cases were recently described in Jorgez <italic>et
al.</italic><sup><xref ref-type="bibr" rid="bib50">50</xref></sup> Patients were
identified through routine etiological work-ups of patients ascertained for
developmental delay/intellectual disability in cytogenetic centers. The
coordinates of the rearrangements’ breakpoints (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>) were recognized by different chromosomal
microarray platforms.</p>
</sec>
<sec>
<title>Lymphoblastoid cell lines and transcriptome profiling</title>
<p>We had previously established by Epstein-Barr virus transformation lymphoblastoid
cell lines (LCLs) from 16p11.2 BP4-BP5 patients, as well as controls. The LCL
transcriptome of 50 deletion and 31 duplication carriers, as well as 17 control
individuals was previously profiled with Affymetrix GeneChips Human Genome
U133+ PM 24 array plates (Affymetrix, Santa Clara, CA, USA). The results are
deposited in the NCBI Gene Expression Omnibus under accession number GSE57802. The
Robust Multi-array Average approach was used for the creation and normalization of
the summarized probe set signals. We applied a nonspecific filter to discard probe
sets with low variability and low signal, that is, detectable expression levels.
Specifically, probe sets with both (i) signal SD&gt;median of signal SD of all
probe sets and (ii) larger signal&gt;median of larger signal of all probe sets
were retained as described in Migliavacca <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib12">12</xref></sup> This selection yielded a total of 23,602 probe sets. To
reduce a potential bias toward genes with multiple probe sets, for the modular
analysis, only one probe set with the highest variance per gene was kept, for a
total of 15,112 probe sets. Using a dosage effect model and moderated
<italic>t</italic>-statistics, we identified 1188 and 2209 significantly differentially
expressed genes (false discovery rate (FDR)⩽1 and 5%, respectively;
uniquely mapping probes).<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> We used
Geneprof to access data pertaining to gene expression and co-regulation.</p>
<p>We are well aware of the limitations of the study of LCLs, for instance for genes
whose expression specificity resides in other cell lineages. These experiments are
nevertheless worth pursuing simply because (i) the primary human target tissues
remain often beyond reach; (ii) we cannot exclude a broad to ubiquitous expression
pattern and chromatin contacts for the genes involved in these disease processes;
and (iii) the pattern of expressions in peripheral tissue may be used as a
biomarker in translational project. Similar limitations apply to the use of
embryonic stem cells-derived material, while animal tissues have a different set
of shortcomings.</p>
</sec>
<sec>
<title>Quantitative reverse transcriptase-PCR</title>
<p>For qPCR, 100 ng of high-quality total RNA was converted to cDNA using
Superscript VILO (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s protocol. Primers were designed using PrimerExpress 2.0
software (Applied Biosystems, Foster City, CA, USA), with default parameters
except for the primer- and minimal amplicon lengths, which were set at 17–26
and 60 bp respectively. The amplification factor of each primer pair was tested
using a cDNA dilution series and only assays with amplification factors between
1.75 and 2.00 were retained. A representative set of samples was tested for
genomic contamination. qPCR experiments were performed in triplicate using
SYBR-Green (Roche, Basel, Switzerland) as reporter. The reaction mixtures were
prepared in 384-well plates using a Freedom Evo robot (Tecan, Männedorf,
Switzerland) and run in an ABI 7900HT sequence detection system (Applied
Biosystems) using the following conditions: 50°C for 2 min, 95°C
for 10 min, followed by 45 cycles of 95°C for 15 s and then 60°C
for 1 min, after which dissociation curves were established. Applicable
normalization genes were included in each experiment to enable compensation for
fluctuations in expression levels between experiments. Using SDS v2.4 software
(Applied Biosystems) the threshold and baseline values were adjusted when
necessary to obtain raw cycle threshold (Ct) values. The Ct values were further
analysed using qBase plus software (Biogazelle, Zwijnaarde, Belgium), which
calculates relative expression values per sample per tested gene upon designation
of the normalization genes and corrects for the amplification efficiency of the
performed assay. We assessed by qPCR the RNA levels of seven DE genes belonging to
the ciliopathy or PTEN pathway (<italic>BBS4</italic> (MIM#600374)<italic>, BBS7</italic>
(MIM#607590)<italic>, BBS10</italic> (MIM#610148)<italic>, XPOT</italic>
(MIM#603180)<italic>, NUP58</italic> (MIM#607615)<italic>, PTPN11</italic>
(MIM#176876) and <italic>SMAD2</italic> (MIM#601366)), and five others that map
either to the BP4-BP5 (<italic>ALDOA</italic> (MIM#103850), <italic>KCTD13, MAPK3</italic>
(MIM#601795) and <italic>MVP</italic> (MIM#605088)) or the BP2-BP3 interval
(<italic>SH2B1</italic> (MIM#608937)) in LCLs from eight carriers of the
220 kb BP2-BP3 deletion, eight carriers of the 600 kb BP4-BP5
deletion and 10 control individuals. In particular, we identified a significant
diminution of the hemizygote gene <italic>SH2B1</italic> but not of the neighboring
normal-copy <italic>KCTD13</italic>, <italic>MVP</italic> and <italic>MAPK3</italic> in BP2-BP3 deletion
carriers.</p>
</sec>
<sec>
<title>Viewpoint selection</title>
<p>We used an adaptation of the 4C method,<sup><xref ref-type="bibr" rid="bib51">51</xref>,
<xref ref-type="bibr" rid="bib52">52</xref>, <xref ref-type="bibr" rid="bib53">53</xref></sup>
the high-resolution Chromosome Conformation Capture Sequencing technology
(4C-seq),<sup><xref ref-type="bibr" rid="bib54">54</xref></sup> to identify
chromosomal regions that physically associate with the promoters of <italic>MVP,
KCTD13, ALDOA, TBX6</italic> (MIM#602427) and <italic>MAPK3</italic>, five of the 28
‘unique’ genes of the BP4-BP5 interval selected according to their
potential role in the described phenotype. Reduction by ∼50% of the RNA
levels of the ortholog of <italic>ALDOA</italic> (Aldolase A) was associated with a change
in brain morphology in zebrafish, suggesting that this gene is dosage
sensitive.<sup><xref ref-type="bibr" rid="bib55">55</xref></sup> In humans, recessive
<italic>ALDOA</italic> deficiency is associated with glycogen storage disease XII
(OMIM#611881).<sup><xref ref-type="bibr" rid="bib56">56</xref></sup>
Morpholino-driven reduction of the expression level of the <italic>KCTD13</italic>
(Potassium Channel Tetramerization Domain containing protein 13) ortholog resulted
in macrocephaly in zebrafish, while its depletion in the brain of mouse embryos
resulted in an increase of proliferating cells. The mirroring microcephaly was
seen upon overexpression of human <italic>KCTD13</italic> cDNA in zebrafish embryos’
heads, a phenotype further amplified upon concomitant overexpression of either
<italic>MAPK3</italic> (mitogen-activated protein kinase 3) or <italic>MVP</italic> (Major
Vault Protein).<sup><xref ref-type="bibr" rid="bib27">27</xref></sup>
<italic>TBX6</italic> (T-Box Transcription Factor 6) is a candidate gene for the vertebral
malformations observed in some deletion carriers since (i) mice homozygous for a
<italic>Tbx6</italic> mutation showed rib and vertebral body anomalies;<sup><xref ref-type="bibr" rid="bib57">57</xref></sup> (ii) <italic>TBX6</italic> polymorphisms were
associated with congenital scoliosis in the Han population;<sup><xref ref-type="bibr" rid="bib58">58</xref></sup> (iii) a stoploss variant in <italic>TBX6</italic>
segregates with congenital spinal defects in a three-generation
family<sup><xref ref-type="bibr" rid="bib59">59</xref></sup> (OMIM#122600); and
(iv) carriers of 16p11.2 600 kb BP4-BP5 deletions and a common hypomorphic
<italic>TBX6</italic> allele suggest a compound inheritance in congenital
scoliosis.<sup><xref ref-type="bibr" rid="bib60">60</xref></sup>
<italic>TBX6</italic> was selected as a viewpoint even though this gene is not expressed
in LCLs (or only at extremely low level), as studies have shown that the contacted
domains are stable across cell lines and tissues regardless of expression
status.<sup><xref ref-type="bibr" rid="bib3">3</xref></sup> Within the group of genes
chromatin-contacted by the above viewpoints we selected two more viewpoints within
the 16p11.2 220 kb BP2-BP3 region (<xref ref-type="fig" rid="fig1">Figure 1</xref>),
that is, the promoters of <italic>SH2B1</italic> and <italic>LAT</italic>. The <italic>SH2B1</italic> gene
was suggested to be a crucial candidate for the obesity phenotype associated with
this genomic interval<sup><xref ref-type="bibr" rid="bib16">16</xref>, <xref ref-type="bibr" rid="bib28">28</xref></sup> as it encodes an Src homology adaptor protein involved
in leptin and insulin signaling.<sup><xref ref-type="bibr" rid="bib61">61</xref>, <xref ref-type="bibr" rid="bib62">62</xref></sup> Common variants in this locus were repeatedly
associated with BMI, serum leptin and body fat in genome-wide association
studies,<sup><xref ref-type="bibr" rid="bib63">63</xref>, <xref ref-type="bibr" rid="bib64">64</xref>, <xref ref-type="bibr" rid="bib65">65</xref>, <xref ref-type="bibr" rid="bib66">66</xref></sup> while rare dominant mutations were reported to cause
obesity, social isolation, aggressive behavior, and speech and language
delay.<sup><xref ref-type="bibr" rid="bib67">67</xref></sup> In a recent large-scale
association study, the deletion was also significantly linked with
SCZ.<sup><xref ref-type="bibr" rid="bib35">35</xref></sup> The <italic>LAT</italic> (linker
for activation of T cells) adaptor molecule participates in AKT activation and
plays an important role in the regulation of lymphocyte maturation, activation and
differentiation.<sup><xref ref-type="bibr" rid="bib68">68</xref>, <xref ref-type="bibr" rid="bib69">69</xref></sup> Its inactivation could be circumvented by Ras/MAPK
constitutive activation.<sup><xref ref-type="bibr" rid="bib70">70</xref></sup></p>
</sec>
<sec>
<title>4C-seq</title>
<p>4C libraries were prepared from LCLs of two control individuals and two carriers
each of the 16p11.2 BP4-BP5 deletion and duplication, sex- and age-matched
(<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). Briefly, LCLs were
grown at 37°C. 5 × 10<sup>7</sup> exponentially growing cells were
harvested and crosslinked with 1% formaldehyde, lysed and cut with DpnII, a
4-cutter restriction enzyme that allows higher resolution.<sup><xref ref-type="bibr" rid="bib53">53</xref></sup> After ligation and reversal of the
crosslinks, the DNA was purified to obtain the 3C library. This 3C library was
further digested with <italic>Nla</italic>III and circularized to obtain a 4C library. The
inverse PCR primers to amplify 4C-seq templates were designed to contain Illumina
adaptor tails, sample barcodes and viewpoint-specific sequences. Viewpoints were
selected at the closest suitable DpnII fragment relative to the transcriptional
start sites of the targeted genes. The sequence of the 4C-seq primers is reported
in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>. For all viewpoints, we
amplified at least 1.6 μg of 4C template (using about 100 ng of
4C template per inverse PCR reaction, for a total number of 16 PCRs). We
multiplexed the 4C-seq templates in equimolar ratios and analyzed them on a 100-bp
single-end Illumina HiSeq flow cell. The numbers of raw, excluded, and mapped
reads for each viewpoint and LCL sample are detailed in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S5</xref>.</p>
</sec>
<sec>
<title>4C-seq data analysis</title>
<p>4C-seq data were analyzed as described in Noordermeer <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib53">53</xref></sup>and Gheldof <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib54">54</xref></sup> through the 4C-seq pipeline available at
<ext-link ext-link-type="uri" xlink:href="http://htsstation.epfl.ch/" xmlns:xlink="http://www.w3.org/1999/xlink">http://htsstation.epfl.ch/</ext-link>)<sup><xref ref-type="bibr" rid="bib71">71</xref></sup> and visualized with gFeatBrowser. Briefly, the multiplexed
samples were separated, undigested and self-ligated reads removed. Remaining reads
were aligned and translated to a virtual library of DpnII fragments. Read counts
were then normalized to the total number of reads and replicates combined by
averaging the resulting signal densities (<xref ref-type="supplementary-material" rid="sup1">Supplementary
Figure S1</xref>). The local correlation between the profiles of the two
samples per viewpoint was calculated (0.46⩽<italic>r</italic><sup>2</sup>⩽0.74 for
controls, 0.29⩽<italic>r</italic><sup>2</sup>⩽0.67 for deletions and
0.22⩽<italic>r</italic><sup>2</sup>⩽0.61 for the duplications). The combined
profiles were then smoothed with a window size of 29 fragments. The region
directly surrounding the viewpoint is usually highly enriched and can show
considerable experimental variation, thereby influencing overall fragment count.
To minimize these effects, the viewpoint itself and the directly neighboring
‘undigested’ fragment were excluded during the procedure. In addition
to this filtering, we modeled the data to apply a profile correction similar to
the one described in Tolhuis <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib72">72</xref></sup> using a fit with a slope −1 in a log–log
scale.<sup><xref ref-type="bibr" rid="bib73">73</xref></sup> Significantly interacting
regions were detected by applying a domainogram analysis as
described.<sup><xref ref-type="bibr" rid="bib74">74</xref></sup> We selected BRICKS
(Blocks of Regulators In Chromosomal Kontext) with a <italic>P</italic>-value threshold
smaller than 0.01 for both ‘<italic>cis</italic>’ and
‘<italic>trans</italic>’ interactions. To determine differentially interacting
regions between the 16p11.2 600 kb BP4-BP5 deletion (Del), duplication
(Dup) and control (Ctrl), we considered all non-null BRICKS found by a domainogram
analysis<sup><xref ref-type="bibr" rid="bib74">74</xref></sup> in either condition and
quantified both signals in each BRICK. The resulting table was scaled to the
sample with the largest interquartile range and the difference of signals was
compared with random in order to associate a <italic>P</italic>-value (FDR) with each
BRICK. Finally, only BRICKS with a <italic>P</italic>-value &lt;0.01 were considered.</p>
<p>All the viewpoints mapping on the BP4-BP5 interval, except <italic>KCTD13</italic>,
contact the 146 and 147 kb long low copy repeats that flank the 16p11
600 kb BP4-BP5 rearrangements. To unravel whether the signal was reflecting
the interaction with the centromeric, the telomeric or both low copy repeats and
given the high similarity (99.5% identity) of the two blocks, we separately
treated the reads mapping within these regions (chr16: 29460515–29606852 and
chr16: 30199854–30346868 according to GRCh 37/<italic>hg19</italic> assembly,
February 2009) using different and more stringent criteria, that is, no mismatch
and unique site mapping. All values were normalized to the total number of reads
mapping to the two regions (per thousands of reads). We observed a higher
proportion of contacts occurring with the centromeric segmental duplication
compared with the telomeric one for <italic>MAPK3</italic> and <italic>TBX6</italic>, while the
trend was reversed for <italic>MVP</italic>, in agreement with their proximity to the
centromeric and telomeric low copy repeat blocks, respectively. No conclusive
results were obtained for <italic>ALDOA</italic>.</p>
</sec>
<sec>
<title>Hi-C data</title>
<p>Hi-C matrices from Rao <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib75">75</xref></sup>
were prepared by first applying a KR normalization to the 5 and 100 kb
resolution observed matrices, and then by dividing each normalized score by the
expected one extracted from the KR expected file (as described in section II.c of
the Extended Experimental Procedures of reference<sup><xref ref-type="bibr" rid="bib75">75</xref></sup>). KR expected values less than 1 were set to 1 to avoid
long-distance interaction biases.</p>
</sec>
<sec>
<title>Enrichment analyses</title>
<p>Gene annotation was obtained through BioScript (<ext-link ext-link-type="uri" xlink:href="http://gdv.epfl.ch/bs" xmlns:xlink="http://www.w3.org/1999/xlink">http://gdv.epfl.ch/bs</ext-link>).
Protein interaction networks for the genes selected by BRICKS calling and from the
list of interacting regions affected by the rearrangements were determined using
STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) v9.1
(<ext-link ext-link-type="uri" xlink:href="http://string-db.org/" xmlns:xlink="http://www.w3.org/1999/xlink">http://string-db.org/</ext-link>).<sup><xref ref-type="bibr" rid="bib76">76</xref></sup>
We exploited Bioscript for Gene Ontology analysis (topGO) (<ext-link ext-link-type="uri" xlink:href="http://gdv.epfl.ch/bs" xmlns:xlink="http://www.w3.org/1999/xlink">http://gdv.epfl.ch/bs</ext-link>), DAVID
GO and KEGG, OMIM Disease and KEGG coupled with Enrichr to assess if the
chromatin-contacted genes were enriched in specific pathways and genes associated
with Mendelian diseases<sup><xref ref-type="bibr" rid="bib77">77</xref>, <xref ref-type="bibr" rid="bib78">78</xref>, <xref ref-type="bibr" rid="bib79">79</xref>, <xref ref-type="bibr" rid="bib80">80</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://www.omim.org/downloads" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.omim.org/downloads</ext-link>). The OMIM gene-set library was
obtained directly from the NCBI’s OMIM Morbid Map.<sup><xref ref-type="bibr" rid="bib81">81</xref></sup> We exploited the SFARI Gene lists and scores (<ext-link ext-link-type="uri" xlink:href="https://sfari.org/" xmlns:xlink="http://www.w3.org/1999/xlink">https://sfari.org/</ext-link>; March 2014
release), the union of the genes cataloged in Girard <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib82">82</xref></sup> and Xu <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib82">82</xref>, <xref ref-type="bibr" rid="bib83">83</xref>, <xref ref-type="bibr" rid="bib84">84</xref></sup> and the genome-wide association studies hits
for BMI<sup><xref ref-type="bibr" rid="bib85">85</xref></sup> to assess enrichment for ASD,
SCZ and BMI genes, respectively. We also used the <italic>de novo</italic> ‘high
confidence’ ASD targets (selected with FDR&lt;0.1 in De Rubeis <italic>et
al.</italic><sup><xref ref-type="bibr" rid="bib86">86</xref></sup> and likely gene disrupting
recurrent mutations target genes in Iossifov <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib87">87</xref></sup>) to assess enrichment of ASD-associated
genes. Ciliary genes enrichment was computed merging the SYSCILIA gold standard
(SCGS) and potential ciliary gene lists (genes with no additional evidence for
ciliary function were excluded).<sup><xref ref-type="bibr" rid="bib88">88</xref></sup> We
used Enrichr Chromosome Location tool and BRICKS count in different window sizes
(5 Mb, 1 Mb and 500 kb) to determine whether any cytogenetic
band other than 16p11.2 was enriched for BRICKS. Other than 16p11.2, we identified
enrichments at 16p12, 16p13, 16q13, 1p36, 11q13, 16q22, 7q31, 15q15 and 1q32
cytobands. As a large proportion of the 16p12.2 BRICKS maps to segmental
duplications that are highly similar to the low copy repeats flanking the 16p11
600 kb BP4-BP5 rearrangements we conservatively did not consider this
region.</p>
<p>All seven tested viewpoints showed enrichment for contacts with loci that encode
proteins that interact together (all <italic>P</italic>&lt;0.01). A single process, focal
adhesion assembly, was shared between the BP2-BP3 and the BP4-BP5 groups of
viewpoints (GO:0048041, <italic>P</italic>=6.02e<sup>−</sup><sup>03</sup> for
the BP2-BP3 group and <italic>P</italic>=1.12e<sup>−03</sup> for the
BP4-BP5). Focal adhesion links the internal actin cytoskeleton to the
extracellular matrix; it is used by cells to explore their environment, and
depends strongly on microtubule dynamics<sup><xref ref-type="bibr" rid="bib89">89</xref></sup> in coordination with the primary cilium.<sup><xref ref-type="bibr" rid="bib90">90</xref>, <xref ref-type="bibr" rid="bib91">91</xref></sup> Genes
participating in focal adhesion (<italic>GSK3B</italic> (MIM#605004)<italic>; PAK7</italic>
(MIM#608038)), axon guidance (<italic>ROBO1</italic> (MIM#602430)<italic>; EPHA6</italic>
(MIM#600066)<italic>; PAK7; GSK3B</italic>) and Golgi apparatus-related processes
(<italic>SND1</italic> (MIM#602181)<italic>; FRMD5</italic> (MIM#616309)) are among the
24 genes <italic>trans</italic>-contacted by both the BP4-BP5 and BP2-BP3 viewpoints. The
gene <italic>MPZL1</italic> (MIM#604376), contacted by both <italic>KCTD13</italic> and
<italic>SH2B1,</italic> is associated with SCZ.<sup><xref ref-type="bibr" rid="bib92">92</xref></sup> It is a downstream target of <italic>PTPN11</italic>.<sup><xref ref-type="bibr" rid="bib93">93</xref></sup></p>
</sec>
<sec>
<title>Fluorescence <italic>in situ</italic> hybridization</title>
<p>Interphase nuclei were prepared from a LCL of a control individual. Fluorescence
<italic>in situ</italic> hybridization experiments were performed using fosmid clones
(300 ng) directly labeled by nick-translation with Cy3-dUTP and
fluorescein-dUTP as previously described<sup><xref ref-type="bibr" rid="bib94">94</xref></sup> with minor modifications. Fosmid and BAC clones
(G248P86150B3 for the <italic>ALDOA</italic> locus, G248P800063B6 for the <italic>SH2B1</italic>
locus; G248P86115A10 for the <italic>KIAA0556</italic> locus; RP11-301D18 for the
<italic>KCTD13</italic> and <italic>MVP</italic> loci; RP11-383D9 for <italic>PTEN</italic>
(MIM#601728); RP11-477N2 for <italic>USP34</italic> (MIM#615295)<italic>/XPO1</italic>
(MIM#602559) and RP11-43E18 for <italic>MARK4</italic> (MIM#606495)) were obtained
from the CHORI BACPAC Resources Center (<ext-link ext-link-type="uri" xlink:href="https://bacpac.chori.org/" xmlns:xlink="http://www.w3.org/1999/xlink">https://bacpac.chori.org/</ext-link>). We picked the
<italic>MARK4</italic>-encompassing BAC as ‘control BAC’ because it maps to a
gene-rich region on chromosome 19, a centrally-positioned chromosome within the
nucleus. Hybridization was performed at 37 °C in 2 × SSC,
50% (v/v) formamide, 10% (w/v) dextran sulfate,
3 μg C0t-1 DNA and 3 μg sonicated salmon sperm DNA in a volume
of 10 μl. Post-hybridization washing was at 60 °C in 0.1
× SSC, three times. Nuclei were DAPI-stained and digital images were
obtained using a Zeiss Imager A1 fluorescence microscope (Carl Zeiss, Oberkochen,
Germany). We considered 50–60 cells per experiment (i.e. at least 100
distances) and co-localization was defined if the distance between signals was
⩽0.3 um. The contact between <italic>SH2B1</italic> and <italic>ALDOA</italic>, versus
the control <italic>KIAA0556,</italic> was estimated by calculating the distance between
BAC probes (median <italic>SH2B1-ALDOA</italic> and <italic>-KIAA0556</italic>
distances=0.43 and 1.24 μm, respectively; Wilcoxon rank-sum test,
<italic>P</italic>=1.45e<sup>−17</sup>). The contact of <italic>MVP</italic> and
<italic>KCTD13</italic> with, respectively, <italic>PTEN</italic> and <italic>USP34/XPO1</italic>,
compared with the control <italic>MARK4,</italic> was estimated as the percentage of
co-localization (25 and 14% co-localization versus 2% with the
control locus; Fisher’s test enrichment:
<italic>P</italic>=6.9e<sup>−05</sup> and <italic>P</italic>=0.01,
respectively; median <italic>MVP/KCTD13-USP34/XPO1</italic> distances=1.76,
<italic>MVP/KCTD13-PTEN</italic>= 2.61 and <italic>MVP/KCTD13-MARK4</italic>
= 4.96 μm; Wilcoxon rank-sum test,
<italic>P</italic>=5.4e<sup>−10</sup> and
<italic>P</italic>=9.3e<sup>−05</sup>, respectively).</p>
</sec>
<sec>
<title>ChIP-seq and RNA-seq molecular associations</title>
<p>Detailed experimental procedures and results are described in Waszak <italic>et
al.</italic><sup><xref ref-type="bibr" rid="bib95">95</xref></sup> Briefly, ChIP-seq
(chromatin immuno-precipitation coupled with sequencing) and mRNA-seq data were
produced from LCLs of 54 individuals of European origin from the 1000 Genomes
Project.<sup><xref ref-type="bibr" rid="bib96">96</xref></sup> ChIP-seq with
antibodies recognizing H3K4me1, H3K4me3, H3K27ac, PU.1 and RNA Pol2 binding, as
well as mRNA-seq gene expression profiling, were carried out from a single growth
of LCLs as previously described.<sup><xref ref-type="bibr" rid="bib97">97</xref></sup>
Genotypes were obtained from the GEUVADIS consortium.<sup><xref ref-type="bibr" rid="bib98">98</xref></sup> To map associations between pairs of ChIP-seq and/or
RNA-seq peaks, we retained 47 individuals after data quality control and proceeded
as follows for each of the 15 possible unordered pairs of distinct molecular
phenotypes (<italic>A</italic><sub><italic>1</italic></sub>, <italic>A</italic><sub>2</sub>). First, we
measured inter-individual Pearson correlation between every possible pair of
normalized quantifications at peaks <italic>(p</italic><sub>1</sub>,
<italic>p</italic><sub>2</sub>) within the 16p11.2 interval (28.1–34.6 Mb)
such that <italic>p</italic><sub>1</sub> and <italic>p</italic><sub>2</sub> belong to
<italic>A</italic><sub>1</sub> and <italic>A</italic><sub>2</sub>, respectively. Note that the
distances here were measured between the respective peak centers, excepted for
mRNA for which we used the transcription start site. Then, we assessed to what
extent the correlations significantly differed from zero by calculating
<italic>P</italic>-values using the R function <italic>cor.test</italic> and corrected them for
multiple-testing by using the Benjamini and Hochberg procedure as implemented in
the R function <italic>p.adjust</italic> (FDR 5 and 10%).</p>
</sec>
</sec>
<sec>
<title>Results</title>
<sec>
<title>Distinct and non-overlapping loci at 16p11.2 are associated with mirror
phenotypes on BMI and HC and autism susceptibility</title>
<p>To comprehensively assess phenotypic features associated with the distal 16p11.2
220 kb BP2-BP3 CNVs (<xref ref-type="fig" rid="fig1">Figure 1</xref>), we collected
de-identified data on 137 unrelated carriers (88 deletions and 49 duplications;
<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1</xref>) and compared BMI and HC
with gender-, age- and geographical location-matched reference population as
described<sup><xref ref-type="bibr" rid="bib18">18</xref></sup> (<xref ref-type="fig" rid="fig2">Figures 2a and b</xref>). The BMI mean <italic>Z</italic>-score of deletion carriers
deviated significantly from that of the general population (<italic>t</italic>-test,
<italic>P</italic>=3.1e<sup>−14</sup>), replicating the earlier described
association of the deletion with obesity.<sup><xref ref-type="bibr" rid="bib16">16</xref>,
<xref ref-type="bibr" rid="bib28">28</xref></sup> We observed a trend towards
increased HC in deletion carriers. The duplication carriers showed a mirroring
decrease of BMI and HC values when compared with those of the control population
(<italic>t</italic>-test, <italic>P</italic>=0.005 and 1.1e<sup>−4</sup>,
respectively). We also observed an increase in ASD prevalence in both deletion
(23/88; 26%) and duplication (11/49; 22%) carriers compared
with the general population (5,338/363,749; 1.5%)<sup><xref ref-type="bibr" rid="bib99">99</xref></sup> (Fisher’s enrichment test:
OR=23.7, <italic>P</italic>=2.5e<sup>−22</sup>; OR=19.4,
<italic>P</italic>=1.2e<sup>−10</sup>) in agreement with published
results.<sup><xref ref-type="bibr" rid="bib29">29</xref>, <xref ref-type="bibr" rid="bib30">30</xref>, <xref ref-type="bibr" rid="bib31">31</xref>, <xref ref-type="bibr" rid="bib32">32</xref>, <xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib34">34</xref>, <xref ref-type="bibr" rid="bib35">35</xref></sup> Thus, genomic
rearrangements at 600 kb BP4-BP5 and 220 kb BP2-BP3, two loci
650 kb apart, present similar clinical patterns: large effect sizes on BMI
and HC, as well as association with ASD.</p>
</sec>
<sec>
<title><italic>Cis</italic>-acting chromatin loops that link the 16p11.2 BP4-BP5 and
BP2-BP3 genomic intervals are perturbed in BP4-BP5 CNV carriers</title>
<p>We posited that the remarkable overlap of phenotypic features associated with the
BP2-BP3 and BP4-BP5 CNVs might derive from the rearrangement-mediated disruption
of the 3D chromatin structure within the 16p11.2 cytoband. To challenge this
hypothesis, we assessed the pattern of chromosomal interactions of selected
‘viewpoints’ from both loci in two LCLs derived from control
individuals using an adapted version of the 4C method (4C-seq: circularized
chromosome conformation capture combined with multiplexed high-throughput
sequencing)<sup><xref ref-type="bibr" rid="bib51">51</xref>, <xref ref-type="bibr" rid="bib52">52</xref>, <xref ref-type="bibr" rid="bib54">54</xref>, <xref ref-type="bibr" rid="bib100">100</xref></sup> (Materials and Methods, <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). Despite the limitations of the study of
LCLs (Materials and Methods), these experiments are worth pursuing as studies have
shown that chromatin contacts are stable across cell lines and tissues regardless
of contacted-gene expression status<sup><xref ref-type="bibr" rid="bib3">3</xref></sup> and
that LCL transcriptome profiles can be recapitulated in other tissues and
species.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> Specifically, our
previous analyses of LCL transcriptomes showed that genes whose expression
correlated with the dosage of the 16p11.2 locus are significantly enriched in
genes associated with ASD and ciliopathies both in human LCLs and mouse
cortex.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> In particular, we
identified chromosomal regions that physically associate with the promoters of
<italic>MVP, KCTD13, ALDOA, TBX6</italic> and <italic>MAPK3,</italic> five genes mapping to the
BP4-BP5 interval, and <italic>SH2B1</italic> and <italic>LAT,</italic> two genes mapping to the
BP2-BP3 one. These were investigated based on their potential role in the
phenotype (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S2</xref>).<sup><xref ref-type="bibr" rid="bib27">27</xref>, <xref ref-type="bibr" rid="bib55">55</xref>, <xref ref-type="bibr" rid="bib57">57</xref>, <xref ref-type="bibr" rid="bib58">58</xref>, <xref ref-type="bibr" rid="bib59">59</xref></sup></p>
<p>Genome-wide we identified an average of 265 BRICKs (FDR⩽1%), i.e.,
three-dimensionally interacting genomic fragments, for the seven viewpoints
(range: 168–442; <xref ref-type="supplementary-material" rid="sup1">Supplementary Tables
S6–S12</xref>). In particular, we observed complex chromatin looping
between genes located in the proximal BP4-BP5 and those mapping both to the distal
BP2-BP3 region and the equidistant downstream region rich in Zn-finger genes
(<xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig3">3a</xref>). For
instance each of the nine genes of the BP2-BP3 interval (<italic>ATXN2L</italic>
(MIM#607931), <italic>TUFM</italic> (MIM#602389)<italic>, SH2B1, ATP2A1</italic>
(MIM#108730)<italic>, RABEP2</italic> (MIM#611869)<italic>, CD19</italic>
(MIM#107265)<italic>, NFATC2IP</italic> (MIM#614525)<italic>, SPNS1</italic>
(MIM#612583) and <italic>LAT</italic>) is contacted by at least one of the five
assessed viewpoints in the BP4-BP5 interval (<xref ref-type="fig" rid="fig1">Figures 1</xref>
and <xref ref-type="fig" rid="fig3">3a</xref>). We reciprocally validated these chromatin
interactions using the promoters of <italic>SH2B1</italic> and <italic>LAT</italic> as viewpoints
(e.g. the chromatin loops of <italic>MVP, KCTD13, ALDOA, TBX6</italic> and <italic>MAPK3</italic>
with <italic>SH2B1</italic> are all recapitulated using <italic>SH2B1</italic> as viewpoint;
<xref ref-type="fig" rid="fig3">Figure 3a</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary
Tables S11 and S12</xref>). The preferential contacted domain of the
BP2-BP3 viewpoints extends proximally to the BP4-BP5 and Zn-finger gene-rich
regions (<xref ref-type="fig" rid="fig3">Figures 3a and b</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S3</xref>). Inversely, significantly less
interactions are called in the gene-rich and equidistant distal region
(<italic>t</italic>-test <italic>P</italic>=0.011, <xref ref-type="supplementary-material" rid="sup1">Supplementary
Figure S3</xref>), suggesting that these interactions do not merely reflect
the spatial clustering of gene-dense regions.</p>
<p>We confirmed the genomic interaction between the 600 kb BP4-BP5 and
220 kb BP2-BP3 intervals using fluorescence <italic>in situ</italic> hybridization.
This independent method showed that the BP2-BP3-mapping <italic>SH2B1</italic> locus was
significantly closer to the BP4-BP5-encompassed <italic>ALDOA</italic> locus than to a
control region, the <italic>KIAA0556</italic> locus, situated equidistantly on its
telomeric side (median <italic>SH2B1-ALDOA</italic> and <italic>SH2B1-KIAA0556</italic>
distances=0.43 and 1.24 μm, respectively; Wilcoxon rank-sum test,
<italic>P</italic>=1.45e<sup>−17</sup>) (<xref ref-type="fig" rid="fig3">Figure
3c</xref>, <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S4</xref>). We also
examined published Hi-C (genome-wide conformation capture) and high-resolution
Hi-C data from LCLs. Although they cannot confirm our chromatin connections given
their limited resolution, they support a preferential three-dimensional proximity
of these two regions<sup><xref ref-type="bibr" rid="bib73">73</xref>, <xref ref-type="bibr" rid="bib75">75</xref></sup> (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). Concordant
results were found in both human IMR90 fibroblasts and embryonic stem
cells<sup><xref ref-type="bibr" rid="bib26">26</xref>, <xref ref-type="bibr" rid="bib101">101</xref></sup> and mouse cortex and embryonic stem cells, suggesting
the conservation of the structure of this topological-associated domain across
species and tissues,<sup><xref ref-type="bibr" rid="bib101">101</xref></sup> as recently
shown for the topological-associated domain spanning the
<italic>WNT6/IHH/EPHA4/PAX3</italic> (MIM#604663; #600726;
#602188; #606597) locus.<sup><xref ref-type="bibr" rid="bib3">3</xref></sup></p>
<p>As chromatin interactions were determined in normal diploid context, we next
assessed the effect of BP4-BP5 CNVs on these chromatin loops. We identified
genomic fragments that interact with the same seven viewpoints in LCLs of two
BP4-BP5 deletion patients and two reciprocal duplication patients (Materials and
Methods). We observed a genome-wide decrease in the number of BRICKS per viewpoint
ranging from 27 to 84%, suggesting that both rearrangements triggered
dramatic reorganizations. Consistent with this hypothesis, the <italic>SH2B1</italic>
viewpoint, whose copy number is not affected by the proximal BP4-BP5 CNV, shows a
36% reduction in the amount of interacting regions (all BRICKS listed in
<xref ref-type="supplementary-material" rid="sup1">Supplementary Tables S13–S26</xref>). We
compared the 4C-seq results from control individuals and the four patients and
identified, across all conditions and considering all viewpoints, 1193 genes with
significantly modified chromosomal contacts (FDR&lt;1% Materials and
Methods, <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S27</xref>). These results
support the idea that large structural rearrangements perturb the 3D genomic
structure by modifying both <italic>cis</italic> and <italic>trans</italic> contacts.</p>
</sec>
<sec>
<title>Perturbations of the chromatin interactions’ landscape at 16p11.2 are
associated with gene expression modification</title>
<p>Our results show that the gene-rich BP2-BP3 and BP4-BP5 16p11.2 intervals, whose
CNVs are linked to overlapping phenotypes, are reciprocally engaged in complex
chromatin looping as determined by 4C, fluorescence <italic>in situ</italic> hybridization
and Hi-C. The recent discovery of multigene complexes where chromosomal loops
orchestrate co-transcription of interacting genes<sup><xref ref-type="bibr" rid="bib2">2</xref>, <xref ref-type="bibr" rid="bib102">102</xref></sup> is suggestive of
functional implications for the chromosomal contacts between the BP2-BP3 and
BP4-BP5 intervals.</p>
<p>To assess this possibility, we first used our recent association analyses of
population-wide transcription factor DNA binding (PU.1 and RPB2—the second
largest subunit of RNA polymerase II), histone modification enrichment patterns
(H3K4me1, H3K4me3 and H3K27ac) and gene expression measured by ChIP-seq and
RNA-seq in LCLs derived from 47 European unrelated individuals whose genomes were
sequenced in the frame of the 1000 Genomes Project.<sup><xref ref-type="bibr" rid="bib95">95</xref></sup> We measured the extent of quantitative coordination of
natural inter-individual variation between pairs of these six molecular phenotypes
at putative regulatory regions mapping within cytoband 16p11.2 and identified
coordinated behavior in terms of mapping enrichment. For example, we found
association between active regulatory regions mapping within the BP4-BP5 interval
and expression of BP2-BP3 genes (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure
S5</xref>),<sup><xref ref-type="bibr" rid="bib95">95</xref></sup> consistent with the
notion that some of the chromatin loops uncovered between these two intervals
might bring together regulatory elements and genes.</p>
<p>Secondly, we examined if genes involved in primary cilium function and related
pathways, which are modified in BP4-BP5 deletion patients’
cells,<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> are also changed in
BP2-BP3 deletion carriers (Materials and Methods). We found that the ciliary genes
<italic>BBS4, BBS7, SMAD2</italic>, <italic>XPOT</italic> and <italic>NUP58</italic> are
correspondingly modified in LCLs derived from both BP4-BP5 and BP2-BP3 deletion
carriers (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S6</xref>). The interplay
between the 600 kb BP4-BP5 and the 220 kb BP2-BP3 interval is
further substantiated: (i) by published data showing perturbed expression of genes
mapping within the BP2-BP3 distal interval (i.e. <italic>LAT, SPNS1</italic> and
<italic>ATP2A1</italic>) in cells derived from BP4-BP5 patients;<sup><xref ref-type="bibr" rid="bib26">26</xref></sup> as well as (ii) by the observation that,
within the top-10 genes correlated with <italic>SH2B1</italic> expression according to
GeneProf (<ext-link ext-link-type="uri" xlink:href="http://www.geneprof.org" xmlns:xlink="http://www.w3.org/1999/xlink">www.geneprof.org</ext-link>),
three (<italic>ZNF500</italic>; <italic>CDAN1</italic> (MIM#607465); <italic>LRRC14</italic>) are
contacted by viewpoints located in the BP4-BP5 region and two (<italic>PIGO</italic>
(MIM#614730)<italic>; TUBGCP6</italic> (MIM#610053)) are differentially
expressed in BP4-BP5 CNV patients.</p>
<p>We then assessed whether the structural chromatin changes identified in the
600 kb BP4-BP5 CNVs carriers (i.e. 1193 genes with significantly modified
chromosomal contacts, FDR&lt;1%) are paralleled by transcriptome
modifications identified in Migliavacca <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib12">12</xref></sup> (2209 significantly differentially expressed genes,
FDR⩽5% uniquely mapping probes)). We find a significant overlap between
the two genes lists as 125 genes with modified chromatin loops are concomitantly
differentially expressed in 16p11.2 600 kb BP4-BP5 CNV carriers’
cells (125/665 4C-modified genes with detectable expression (see Materials and
Methods); Fisher’s enrichment test: OR=1.4, <italic>P</italic>=0.002;
<xref ref-type="supplementary-material" rid="sup1">Supplementary Tables S28–S30</xref> and <xref ref-type="fig" rid="fig4">Figure 4a</xref>). There is no correlation between quality of the
change in 4C contact (increased or decreased) and the sense of the perturbation in
gene expression, that is, a loss of contact does not necessarily imply a decrease
in expression and vice versa (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure
S7</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S31</xref>).</p>
<p>These results show that the BP2-BP3 and BP4-BP5 loci are linked by chromatin
loops, coordinated molecular phenotypes and co-regulation of genes.</p>
</sec>
<sec>
<title>Genomic regions contacted by 16p11.2 viewpoints are associated with autism,
BMI and HC phenotypes and enriched in ciliary genes</title>
<p>Consistent with the notion that chromatin contacts connect biologically related
genes, BRICKs genes are enriched for genes that encode proteins that interact
(<italic>P</italic>&lt;0.01 for all viewpoints; <xref ref-type="supplementary-material" rid="sup1">Supplementary
Table S32</xref>, Materials and Methods). Processes overrepresented within
BRICKs genes are listed in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table
S33</xref>. They are also enriched for genes listed in SFARI Gene (<ext-link ext-link-type="uri" xlink:href="https://sfari.org/" xmlns:xlink="http://www.w3.org/1999/xlink">https://sfari.org/</ext-link>), an
annotated list of candidate genes for ASD (union of the SFARI Syndromic, High
Confidence and Strong Candidate Gene categories (Categories S+1-2),
13/76, OR=2.9, <italic>P</italic>=0.0014) and for ASD-associated genes
identified by whole-exome studies (8/50 of the ‘high confidence <italic>de
novo</italic>’ ASD-associated genes;<sup><xref ref-type="bibr" rid="bib86">86</xref>,
<xref ref-type="bibr" rid="bib87">87</xref></sup> OR=2.7,
<italic>P</italic>=0.016; <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S34</xref>).
The BP4-BP5 and BP2-BP3 viewpoints contacted genes include <italic>GRID1</italic>
(MIM#610659) and <italic>PTEN</italic> at 10q23.2–q23.31,
<italic>USP34</italic>/<italic>XPO1</italic> at 2p15, but also genes linked to HC
phenotypes like <italic>CHD1L</italic> (MIM#613039) at 1q21.1<sup><xref ref-type="bibr" rid="bib103">103</xref>, <xref ref-type="bibr" rid="bib104">104</xref>, <xref ref-type="bibr" rid="bib105">105</xref>, <xref ref-type="bibr" rid="bib106">106</xref>, <xref ref-type="bibr" rid="bib107">107</xref>, <xref ref-type="bibr" rid="bib108">108</xref>, <xref ref-type="bibr" rid="bib109">109</xref>, <xref ref-type="bibr" rid="bib110">110</xref>, <xref ref-type="bibr" rid="bib111">111</xref>, <xref ref-type="bibr" rid="bib112">112</xref></sup> and
<italic>EP300</italic> (MIM#602700) at 22q13<sup><xref ref-type="bibr" rid="bib113">113</xref></sup> (<xref ref-type="fig" rid="fig5">Figure 5a</xref>, <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S8</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S35</xref>). To validate these interactions, we
verified a subset by fluorescence <italic>in situ</italic> hybridization (e.g.
<italic>MVP-PTEN</italic> and <italic>KCTD13</italic>-<italic>USP34/</italic>XPO1; <xref ref-type="fig" rid="fig5">Figures 5b–e</xref> and Materials and Methods). The
comparison of distributions of Hi-C scores in selected versus non-selected BRICKS
for each of our 4C viewpoints (Materials and Methods) further demonstrates the
reproducibility of the 4C results (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure
S9</xref>).</p>
<p>Reminiscent of our transcriptome findings,<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> enrichment analysis of the 1193 genes with modified
chromosomal contacts showed significant over-representation of ciliary
genes<sup><xref ref-type="bibr" rid="bib88">88</xref></sup> (40/493,
OR=1.47, <italic>P</italic>=0.030, <xref ref-type="supplementary-material" rid="sup1">Supplementary Tables
S29–30</xref>), OMIM terms associated with dysfunction of ciliary
structures (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S28</xref>) and candidate
genes for ASD (<xref ref-type="supplementary-material" rid="sup1">Supplementary Tables
S29–S30</xref>). We showed previously<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> that differentially expressed genes were similarly
enriched for SFARI-ASD-associated genes (91/323 with detectable expression;
OR=2.3, <italic>P</italic>=2.43e<sup>−10</sup>; <xref ref-type="fig" rid="fig4">Figure 4a</xref>). Notably five (<italic>TCF4</italic> (MIM#602272)<italic>, EP300,
ADK</italic> (MIM#102750)<italic>, TUBGCP5</italic> (MIM#608147)<italic>, VPS13B</italic>
(MIM#607817)) of the 12 genes that are concurrently SFARI-ASD, differentially
expressed and modified in 4C contacts (OR=5.01,
<italic>P</italic>=1.5e<sup>−05</sup>) were previously associated with
head circumference changes<sup><xref ref-type="bibr" rid="bib114">114</xref>, <xref ref-type="bibr" rid="bib115">115</xref>, <xref ref-type="bibr" rid="bib116">116</xref>, <xref ref-type="bibr" rid="bib117">117</xref></sup> (<xref ref-type="fig" rid="fig4">Figures 4a and
b</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Tables S29 and
S30</xref>).</p>
</sec>
<sec>
<title>Phenotypes associated with 2p15-16.1 CNVs</title>
<p>Our results suggest that chromatin interactions captured by the BP4-BP5 and
BP2-BP3 viewpoints and their perturbations can be exploited to identify additional
genes/loci, which when genetically perturbed, are associated with similar
pathways, diseases and phenotypes. We challenged this hypothesis by assessing
whether the phenotypic features of 2p15-p16.1 deletion and duplication carriers
overlap with those of carriers of the 600 kb BP4-BP5 and 220 kb
BP2-BP3 rearrangements. Haploinsufficiency of the chromatin-contacted
<italic>USP34</italic>/<italic>XPO1</italic> was suggested to be responsible for the
2p15-p16.1 deletion syndrome (MIM#612513) phenotypes that included
intellectual disability, ASD, microcephaly, dysmorphic facial features and a
variety of congenital organ defects.<sup><xref ref-type="bibr" rid="bib111">111</xref>,
<xref ref-type="bibr" rid="bib112">112</xref></sup></p>
<p>We collected clinical data on 26 and 9 unrelated 2p15-p16.1 deletion and
duplication carriers, respectively (<xref ref-type="fig" rid="fig2">Figure 2c</xref> and
<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>). Comparison of data on
BMI and HC of both variants pinpoints mirror phenotypes for these two traits
(<xref ref-type="fig" rid="fig2">Figures 2d and e</xref>). Whereas we do not formally
demonstrate a mechanistic and functional link between the 600 kb BP4-BP5
and the 2p15 interval, it should be noted that the
<italic>KCTD13</italic>–<italic>USP34/XPO1</italic> interactions are present in
controls LCLs, but neither in 16p11.2 deletion nor duplication LCLs (see below).
Furthermore, five (<italic>C2orf74, COMMD1</italic> (MIM#607238)<italic>, FAM161A</italic>
(MIM#613596)<italic>, PEX13</italic> (MIM#601789)<italic>, PUS10</italic>
(MIM#612787)) and 11 (<italic>AHSA2, BCL11A</italic> (MIM#606557)<italic>, PAPOLG,
REL</italic> (MIM#164910)<italic>, USP34, XPO1</italic>) of the 13 genes mapping within
the 2p15-16.1 syndrome minimal overlapping interval<sup><xref ref-type="bibr" rid="bib111">111</xref>, <xref ref-type="bibr" rid="bib112">112</xref></sup> show perturbed
expression levels in 16p11.2 CNV patients with cutoffs of 5 and 15% FDR,
respectively. Thus, the <italic>cis</italic>- and <italic>trans</italic>-chromatin contacts we
uncovered bridge genomic regions, whose rearrangements are associated with ASD and
mirror phenotypes on BMI and HC.</p>
</sec>
</sec>
<sec>
<title>Discussion</title>
<p>The 16p11.2 600 kb BP4-BP5 rearrangements allow investigation of molecular
mechanisms underlying the co-morbidity triad of neurodevelopmental disorders, energy
imbalance and HC alterations, all associated with changes in gene dosage. To identify
pathways that are perturbed when the dosage of this region is modified we cataloged
the chromosomal contacts of genes mapping within this genomic interval. Using
chromosome conformation capture we uncovered a network of chromatin loops with genes
previously associated with ASD and HC demonstrating the pertinence of this approach.
We show, for example, that the 16p11.2 phenotype drivers <italic>MVP</italic> and
<italic>MAPK3</italic> promoters have long-range chromatin interactions with <italic>PTEN</italic>
and <italic>CHD1L</italic>, respectively. The MVP protein regulates the intracellular
localization of PTEN,<sup><xref ref-type="bibr" rid="bib118">118</xref></sup> a
dual-specificity phosphatase that antagonizes PI3K/AKT and Ras/MAPK signaling
pathways. Both <italic>PTEN</italic> germline mutations in humans and targeted inactivation
in mice are associated with macrocephaly/ASD syndrome
(MIM#605309).<sup><xref ref-type="bibr" rid="bib103">103</xref>, <xref ref-type="bibr" rid="bib104">104</xref>, <xref ref-type="bibr" rid="bib105">105</xref>, <xref ref-type="bibr" rid="bib106">106</xref>, <xref ref-type="bibr" rid="bib119">119</xref></sup>
Congruently, germline mutations in the Ras/MAPK pathway cause a group of
syndromes frequently regrouped under the term RASopathies, recently shown to affect
social interactions.<sup><xref ref-type="bibr" rid="bib120">120</xref>, <xref ref-type="bibr" rid="bib121">121</xref></sup> We corroboratingly revealed that expression of
<italic>PTEN</italic> pathway members is sensitive to gene dosage at the 16p11.2
locus.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup>
<italic>CHD1L</italic> was suggested to be a major driver of the phenotypes associated with
1q21.1 rearrangements (OMIM#612474; #612475).<sup><xref ref-type="bibr" rid="bib107">107</xref>, <xref ref-type="bibr" rid="bib108">108</xref></sup> Analogous to 16p11.2,
deletions and duplications of this interval are linked to micro- and macrocephaly,
respectively.<sup><xref ref-type="bibr" rid="bib109">109</xref></sup></p>
<p>These results suggest that chromatin interactions, even when tested in peripheral
tissues (such as LCLs) not considered to play a central role in the resulting
neurodevelopmental phenotype, could reveal genes or pathways, which are co-regulated
and associated with similar phenotypes. Several studies have shown that the contacted
domains can be highly stable across species and cell lines (even when the contacted
genes are not expressed),<sup><xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib101">101</xref></sup> supporting the notion that patient-derived samples can
provide direct insight into regulatory abnormalities and that LCLs still contain
valuable information for the study of the patients phenotype.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> Consistent with this hypothesis, we established
that dosage perturbation of two chromatin-contacted loci, the <italic>cis</italic>-contacted
16p11.2 220 kb BP2-BP3 and the <italic>trans</italic>-interacting 2p15 intervals, are
associated with mirror phenotypes on BMI and HC. Similar regulatory cores engaged in
multiple physical interactions were recently described, for example, the 8q24
oncogenetic locus.<sup><xref ref-type="bibr" rid="bib122">122</xref></sup></p>
<p>The physiological relevance of the underlying chromatin architecture is further
exemplified by the extensive overlap between differentially expressed genes and the
loci that show modified loops upon dosage changes of the 16p11.2 600 kb
BP4-BP5 interval. Together with the observed enrichments in various
pathology-relevant gene ontology terms and pathways, this sheds light on a possible
‘chromatin hub’ role of the 16p11.2 locus in the observed phenotypes. The
12 genes that are concurrently SFARI-ASD, differentially expressed and modified in 4C
contacts include (i) <italic>VPS13B</italic>, whose mutations cause Cohen syndrome
(OMIM#216550), an autosomal recessive disorder characterized by intellectual
disability, microcephaly, retinal dystrophy and truncal obesity;<sup><xref ref-type="bibr" rid="bib123">123</xref></sup> (ii) <italic>TCF4</italic>, whose haploinsufficiency
is associated with Pitt-Hopkins syndrome (OMIM#610954) typified among other
traits by intellectual disability, recurrent seizures and microcephaly (Of note, the
expression level of this transcription factor of the Wnt/β-catenin signaling
cascade was shown to be altered in the cortex of mice models engineered to carry one
or three copies of the 16p11.2 orthologous region<sup><xref ref-type="bibr" rid="bib26">26</xref></sup>); (iii) the <italic>TSC2</italic> (MIM#191092) tuberous
sclerosis (OMIM#613254) gene, which encodes an inhibitor of mTORC1 signaling that
limits cell growth and was linked to ciliary dysfunction;<sup><xref ref-type="bibr" rid="bib124">124</xref></sup> and (iv) <italic>EP300</italic>, which is mutated in a form of
Rubinstein-Taybi syndrome 2 (OMIM#613684) associated with a more severe
microcephaly.<sup><xref ref-type="bibr" rid="bib114">114</xref>, <xref ref-type="bibr" rid="bib125">125</xref></sup></p>
<p>Whereas the functions and natures of the detected contacts remain to be elucidated,
recent reports show that transcription of co-regulated genes occurs in the context of
spatial proximity, which is lost in knockout studies.<sup><xref ref-type="bibr" rid="bib2">2</xref>, <xref ref-type="bibr" rid="bib102">102</xref></sup> While we cannot exclude
that the observed proximal positions of genes is brought about by proteins that do
not directly interact with any of them<sup><xref ref-type="bibr" rid="bib126">126</xref></sup>
or occur through their use of identical transcription factory for
example,<sup><xref ref-type="bibr" rid="bib127">127</xref>, <xref ref-type="bibr" rid="bib128">128</xref></sup> we <italic>de facto</italic> witness that expression of multiple
genes of converging pathways is modified and that the chromatin-contacted genes are
encoding proteins of overlapping interactomes (<xref ref-type="fig" rid="fig4">Figure 4c</xref>
and <xref ref-type="supplementary-material" rid="sup1">Supplementary Figures S10–S11</xref>). For
example, <italic>MVP</italic> loops with genes implicated in maintenance of cell polarity
(<italic>P</italic>=2.75e<sup>−03</sup>) (<xref ref-type="supplementary-material" rid="sup1">Supplementary
Table S33</xref>).</p>
<p>Chromatin spatial organization is conserved, to some extent at least, through
evolution.<sup><xref ref-type="bibr" rid="bib129">129</xref></sup> The distal and
proximal 16p11.2 regions are physically interacting in both human and mouse
cells.<sup><xref ref-type="bibr" rid="bib73">73</xref>, <xref ref-type="bibr" rid="bib101">101</xref></sup> This chromatin crosstalk is preserved despite
modifications in the human lineage of the orientation of both the BP2-BP3 and the
BP4-BP5 regions, as well as doubling of the size of the intervening region. While we
cannot rule out that similar studies on the clinically relevant tissues might uncover
additional important partners, these studies demonstrate that maintenance of
chromatin crosstalk across tissues (from fibroblasts to cortical neurons) and in
different lineages lends credence to the use of LCLs and animal models as proxies to
study chromatin properties of the human central nervous system, the more likely
tissue determining the phenotypes associated with 16p11.2 600 kb BP4-BP5 and
BP2-BP3 CNVs.</p>
<p>The identified <italic>cis</italic>- and <italic>trans</italic>-chromatin contacts bridge loci whose
rearrangements result in mirror phenotypes on BMI and HC, as well as involve known
ASD candidate genes. While investigations of the 3D genomic structures of additional
regions are warranted, the results present here support the idea that the elucidation
of chromatin contacts can be proposed as a new and effective tool to unravel genes
participating in similar pathways or disease mechanisms, and identify loci associated
with overlapping phenotypic manifestations. Our study also suggests that
modifications of chromatin interplays play a crucial role in the observed
phenotypes.</p>
</sec>
<sec>
<title>Accession numbers</title>
<p>GEO Seriegs accession number: GSE57802.</p>
</sec>
<sec>
<title>The Web Resources section</title>
<p>4C-seq pipeline: <ext-link ext-link-type="uri" xlink:href="http://htsstation.epfl.ch/" xmlns:xlink="http://www.w3.org/1999/xlink">http://htsstation.epfl.ch/</ext-link>BioScript: <ext-link ext-link-type="uri" xlink:href="http://gdv.epfl.ch/bs" xmlns:xlink="http://www.w3.org/1999/xlink">http://gdv.epfl.ch/bs</ext-link>GeneProf: <ext-link ext-link-type="uri" xlink:href="http://www.geneprof.org" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.geneprof.org</ext-link>GTEx: <ext-link ext-link-type="uri" xlink:href="http://www.gtexportal.org/home/" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.gtexportal.org/home/</ext-link>gFeatBrowser: <ext-link ext-link-type="uri" xlink:href="http://www.gfeatbrowser.com" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.gfeatbrowser.com</ext-link>. Online
Mendelian Inheritance in Man: <ext-link ext-link-type="uri" xlink:href="http://www.omim.org" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.omim.org</ext-link>SFARI: <ext-link ext-link-type="uri" xlink:href="https://sfari.org/" xmlns:xlink="http://www.w3.org/1999/xlink">https://sfari.org/</ext-link>STRING: <ext-link ext-link-type="uri" xlink:href="http://string-db.org/" xmlns:xlink="http://www.w3.org/1999/xlink">http://string-db.org/</ext-link>.</p>
</sec>
</body>
<back>
<ack>
<p>We thank the members of the Lausanne Genomic Technologies Facility and Jacqueline Chrast
for technical help and Catia Attanasio for comments on the manuscript. NG is a grantee
of the Marie Heim Vögtlin and the Pro-Women programs of the SNSF and the Faculty of
Biology and Medicine, University of Lausanne, respectively. KM was awarded a fellowship
from the Swiss Scientific Exchange NMS Program. IvdW was recipient of scholarships from
the Nora Baart Foundation and Erasmus European Union Lifelong Learning Programme. AAA
was awarded a scholarship from the Saudi Arabian National Guard Health Affairs. SMW was
supported by SNSF (Swiss National Science Foundation)(P2ELP3_155365) and EMBO (ALTF
755-2014) fellowships. SJ is recipient of a SNSF Bursary Professor fellowship. This work
is supported by grants from the Simons Foundation (SFARI274424 to AR), the Swiss
National Science Foundation 31003A_160203 (AR), SNSF Sinergia grants CRSII33-133044 (AR)
and CRSI33-130326 (ETD, BD, AR), the Leenaards Foundation Prize (SJ, AR) and the
SystemsX.ch initiative grant 3826 (ETD and AR). The funders had no role in study design,
data collection and analysis, decision to publish or preparation of the manuscript.</p>
<p>
<bold>Author contributions</bold>
</p>
<p>MNL, NG and GG performed the 4C and FISH experiments. ML, MNL, EM, AAA and JR conducted
the statistical analyses. KM, MNL and IvdW established cell lines. IvdW, KM and MZ
performed the qPCR experiments. SMW, ETD and BD run the molecular associations. IRC, KM,
IvdW, MP, LH, AMM, RFK, DS, JAR, LGS, JA, CM, SWS, YS, JFG, UT, GT, JSB, SJ and all
other members of the 16p11.2 and 2p15 consortia phenotyped and genotyped individuals.
MNL and AR wrote the manuscript with contributions from GG, JSB and SJ. AR designed the
study and obtained the necessary funding. All authors commented on and approved the
manuscript.</p>
</ack>
<fn-group>
<fn>
<p><xref ref-type="supplementary-material" rid="sup1">Supplementary Information</xref> accompanies the paper on the
Molecular Psychiatry website (http://www.nature.com/mp)</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</fn-group>
<ref-list>
<ref id="bib1">
<mixed-citation publication-type="journal">de Laat W, Duboule D. <article-title>Topology of mammalian developmental enhancers and their regulatory
landscapes</article-title>. <source/>Nature
<year>2013</year>; <volume>502</volume>: <fpage>499</fpage>–506.<pub-id pub-id-type="pmid">24153303</pub-id></mixed-citation>
</ref>
<ref id="bib2">
<mixed-citation publication-type="journal">Fanucchi S, Shibayama Y, Burd S, Weinberg MS, Mhlanga MM. <article-title>Chromosomal contact permits transcription between coregulated genes</article-title>. <source/>Cell
<year>2013</year>; <volume>155</volume>: <fpage>606</fpage>–620.<pub-id pub-id-type="pmid">24243018</pub-id></mixed-citation>
</ref>
<ref id="bib3">
<mixed-citation publication-type="journal">Lupianez DG, Kraft K, Heinrich V, Krawitz P, Brancati F, Klopocki E et al. <article-title>Disruptions of topological chromatin domains cause pathogenic rewiring of
gene-enhancer interactions</article-title>. <source/>Cell
<year>2015</year>; <volume>161</volume>: <fpage>1012</fpage>–1025.<pub-id pub-id-type="pmid">25959774</pub-id></mixed-citation>
</ref>
<ref id="bib4">
<mixed-citation publication-type="journal">Lupianez DG, Spielmann M, Mundlos S. <article-title>Breaking TADs: how alterations of chromatin domains result in disease</article-title>. <source/>Trends Genet
<year>2016</year>; <volume>32</volume>: <fpage>225</fpage>–237.<pub-id pub-id-type="pmid">26862051</pub-id></mixed-citation>
</ref>
<ref id="bib5">
<mixed-citation publication-type="journal">Johnson ME, Viggiano L, Bailey JA, Abdul-Rauf M, Goodwin G, Rocchi M et al. <article-title>Positive selection of a gene family during the emergence of humans and African
apes</article-title>. <source/>Nature
<year>2001</year>; <volume>413</volume>: <fpage>514</fpage>–519.<pub-id pub-id-type="pmid">11586358</pub-id></mixed-citation>
</ref>
<ref id="bib6">
<mixed-citation publication-type="journal">Antonacci F, Kidd JM, Marques-Bonet T, Teague B, Ventura M, Girirajan S et al. <article-title>A large and complex structural polymorphism at 16p12.1 underlies microdeletion
disease risk</article-title>. <source/>Nat Genet
<year>2010</year>; <volume>42</volume>: <fpage>745</fpage>–750.<pub-id pub-id-type="pmid">20729854</pub-id></mixed-citation>
</ref>
<ref id="bib7">
<mixed-citation publication-type="journal">Giannuzzi G, Migliavacca E, Reymond A. <article-title>Novel H3K4me3 marks are enriched at human- and chimpanzee-specific cytogenetic
structures</article-title>. <source/>Genome Res
<year>2014</year>; <volume>24</volume>: <fpage>1455</fpage>–1468.<pub-id pub-id-type="pmid">24916972</pub-id></mixed-citation>
</ref>
<ref id="bib8">
<mixed-citation publication-type="journal">Ballif BC, Hornor SA, Jenkins E, Madan-Khetarpal S, Surti U, Jackson KE et al. <article-title>Discovery of a previously unrecognized microdeletion syndrome of
16p11.2-p12.2</article-title>. <source/>Nat Genet
<year>2007</year>; <volume>39</volume>: <fpage>1071</fpage>–1073.<pub-id pub-id-type="pmid">17704777</pub-id></mixed-citation>
</ref>
<ref id="bib9">
<mixed-citation publication-type="journal">Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R et al. <article-title>Association between microdeletion and microduplication at 16p11.2 and
autism</article-title>. <source/>N Engl J Med
<year>2008</year>; <volume>358</volume>: <fpage>667</fpage>–675.<pub-id pub-id-type="pmid">18184952</pub-id></mixed-citation>
</ref>
<ref id="bib10">
<mixed-citation publication-type="journal">Girirajan S, Rosenfeld JA, Cooper GM, Antonacci F, Siswara P, Itsara A et al. <article-title>A recurrent 16p12.1 microdeletion supports a two-hit model for severe
developmental delay</article-title>. <source/>Nat Genet
<year>2010</year>; <volume>42</volume>: <fpage>203</fpage>–209.<pub-id pub-id-type="pmid">20154674</pub-id></mixed-citation>
</ref>
<ref id="bib11">
<mixed-citation publication-type="journal">Hastings PJ, Lupski JR, Rosenberg SM, Ira G. <article-title>Mechanisms of change in gene copy number</article-title>. <source/>Nat Rev Genet
<year>2009</year>; <volume>10</volume>: <fpage>551</fpage>–564.<pub-id pub-id-type="pmid">19597530</pub-id></mixed-citation>
</ref>
<ref id="bib12">
<mixed-citation publication-type="journal">Migliavacca E, Golzio C, Mannik K, Blumenthal I, Oh EC, Harewood L et al. <article-title>A potential contributory role for ciliary dysfunction in the 16p11.2 600 kb
BP4-BP5 pathology</article-title>. <source/>Am J Hum Genet
<year>2015</year>; <volume>96</volume>: <fpage>784</fpage>–796.<pub-id pub-id-type="pmid">25937446</pub-id></mixed-citation>
</ref>
<ref id="bib13">
<mixed-citation publication-type="journal">Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S et al. <article-title>Autism genome-wide copy number variation reveals ubiquitin and neuronal
genes</article-title>. <source/>Nature
<year>2009</year>; <volume>459</volume>: <fpage>569</fpage>–573.<pub-id pub-id-type="pmid">19404257</pub-id></mixed-citation>
</ref>
<ref id="bib14">
<mixed-citation publication-type="journal">Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J et al. <article-title>Structural variation of chromosomes in autism spectrum disorder</article-title>. <source/>Am J Hum Genet
<year>2008</year>; <volume>82</volume>: <fpage>477</fpage>–488.<pub-id pub-id-type="pmid">18252227</pub-id></mixed-citation>
</ref>
<ref id="bib15">
<mixed-citation publication-type="journal">Zufferey F, Sherr EH, Beckmann ND, Hanson E, Maillard AM, Hippolyte L et al. <article-title>A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and
neuropsychiatric disorders</article-title>. <source/>J Med Genet
<year>2012</year>; <volume>49</volume>: <fpage>660</fpage>–668.<pub-id pub-id-type="pmid">23054248</pub-id></mixed-citation>
</ref>
<ref id="bib16">
<mixed-citation publication-type="journal">Bochukova EG, Huang N, Keogh J, Henning E, Purmann C, Blaszczyk K et al. <article-title>Large, rare chromosomal deletions associated with severe early-onset
obesity</article-title>. <source/>Nature
<year>2010</year>; <volume>463</volume>: <fpage>666</fpage>–670.<pub-id pub-id-type="pmid">19966786</pub-id></mixed-citation>
</ref>
<ref id="bib17">
<mixed-citation publication-type="journal">Walters RG, Jacquemont S, Valsesia A, de Smith AJ, Martinet D, Andersson J et al. <article-title>A new highly penetrant form of obesity due to deletions on chromosome
16p11.2</article-title>. <source/>Nature
<year>2010</year>; <volume>463</volume>: <fpage>671</fpage>–675.<pub-id pub-id-type="pmid">20130649</pub-id></mixed-citation>
</ref>
<ref id="bib18">
<mixed-citation publication-type="journal">Jacquemont S, Reymond A, Zufferey F, Harewood L, Walters RG, Kutalik Z et al. <article-title>Mirror extreme BMI phenotypes associated with gene dosage at the chromosome
16p11.2 locus</article-title>. <source/>Nature
<year>2011</year>; <volume>478</volume>: <fpage>97</fpage>–102.<pub-id pub-id-type="pmid">21881559</pub-id></mixed-citation>
</ref>
<ref id="bib19">
<mixed-citation publication-type="journal">Shinawi M, Liu P, Kang SH, Shen J, Belmont JW, Scott DA et al. <article-title>Recurrent reciprocal 16p11.2 rearrangements associated with global developmental
delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size</article-title>. <source/>J Med Genet
<year>2010</year>; <volume>47</volume>: <fpage>332</fpage>–341.<pub-id pub-id-type="pmid">19914906</pub-id></mixed-citation>
</ref>
<ref id="bib20">
<mixed-citation publication-type="journal">Reinthaler EM, Lal D, Lebon S, Hildebrand MS, Dahl HH, Regan BM et al. <article-title>16p11.2 600 kb duplications confer risk for typical and atypical Rolandic
epilepsy</article-title>. <source/>Hum Mol Genet
<year>2014</year>; <volume>23</volume>: <fpage>6069</fpage>–6080.<pub-id pub-id-type="pmid">24939913</pub-id></mixed-citation>
</ref>
<ref id="bib21">
<mixed-citation publication-type="journal">Dimassi S, Labalme A, Lesca G, Rudolf G, Bruneau N, Hirsch E et al. <article-title>A subset of genomic alterations detected in rolandic epilepsies contains
candidate or known epilepsy genes including GRIN2A and PRRT2</article-title>. <source/>Epilepsia
<year>2014</year>; <volume>55</volume>: <fpage>370</fpage>–378.<pub-id pub-id-type="pmid">24372385</pub-id></mixed-citation>
</ref>
<ref id="bib22">
<mixed-citation publication-type="journal">McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S et al. <article-title>Microduplications of 16p11.2 are associated with schizophrenia</article-title>. <source/>Nat Genet
<year>2009</year>; <volume>41</volume>: <fpage>1223</fpage>–1227.<pub-id pub-id-type="pmid">19855392</pub-id></mixed-citation>
</ref>
<ref id="bib23">
<mixed-citation publication-type="journal">D'Angelo D, Lebon S, Chen Q, Martin-Brevet S, Snyder LG, Hippolyte L et al. <article-title>Defining the effect of the 16p11.2 duplication on cognition, behavior, and
medical comorbidities</article-title>. <source/>JAMA Psychiatry
<year>2016</year>; <volume>73</volume>: <fpage>20</fpage>–30.<pub-id pub-id-type="pmid">26629640</pub-id></mixed-citation>
</ref>
<ref id="bib24">
<mixed-citation publication-type="journal">Mannik K, Magi R, Mace A, Cole B, Guyatt AL, Shihab HA et al. <article-title>Copy number variations and cognitive phenotypes in unselected
populations</article-title>. <source/>JAMA
<year>2015</year>; <volume>313</volume>: <fpage>2044</fpage>–2054.<pub-id pub-id-type="pmid">26010633</pub-id></mixed-citation>
</ref>
<ref id="bib25">
<mixed-citation publication-type="journal">Maillard AM, Ruef A, Pizzagalli F, Migliavacca E, Hippolyte L, Adaszewski S et al. <article-title>The 16p11.2 locus modulates brain structures common to autism, schizophrenia and
obesity</article-title>. <source/>Mol Psychiatry
<year>2015</year>; <volume>20</volume>: <fpage>140</fpage>–147.<pub-id pub-id-type="pmid">25421402</pub-id></mixed-citation>
</ref>
<ref id="bib26">
<mixed-citation publication-type="journal">Blumenthal I, Ragavendran A, Erdin S, Klei L, Sugathan A, Guide JR et al. <article-title>Transcriptional consequences of 16p11.2 deletion and duplication in mouse cortex
and multiplex autism families</article-title>. <source/>Am J Hum Genet
<year>2014</year>; <volume>94</volume>: <fpage>870</fpage>–883.<pub-id pub-id-type="pmid">24906019</pub-id></mixed-citation>
</ref>
<ref id="bib27">
<mixed-citation publication-type="journal">Golzio C, Willer J, Talkowski ME, Oh EC, Taniguchi Y, Jacquemont S et al. <article-title>KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2
copy number variant</article-title>. <source/>Nature
<year>2012</year>; <volume>485</volume>: <fpage>363</fpage>–367.<pub-id pub-id-type="pmid">22596160</pub-id></mixed-citation>
</ref>
<ref id="bib28">
<mixed-citation publication-type="journal">Walters RG, Coin LJ, Ruokonen A, de Smith AJ, El-Sayed Moustafa JS, Jacquemont S et al. <article-title>Rare genomic structural variants in complex disease: lessons from the
replication of associations with obesity</article-title>. <source/>PLoS One
<year>2013</year>; <volume>8</volume>: <fpage>e58048</fpage>.<pub-id pub-id-type="pmid">23554873</pub-id></mixed-citation>
</ref>
<ref id="bib29">
<mixed-citation publication-type="journal">Barge-Schaapveld DQ, Maas SM, Polstra A, Knegt LC, Hennekam RC. <article-title>The atypical 16p11.2 deletion: a not so atypical microdeletion syndrome</article-title>? <source/>Am J Med Genet A
<year>2011</year>; <volume>155A</volume>: <fpage>1066</fpage>–1072.<pub-id pub-id-type="pmid">21465664</pub-id></mixed-citation>
</ref>
<ref id="bib30">
<mixed-citation publication-type="journal">Bachmann-Gagescu R, Mefford HC, Cowan C, Glew GM, Hing AV, Wallace S et al. <article-title>Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated
with developmental delay and obesity</article-title>. <source/>Genet Med
<year>2010</year>; <volume>12</volume>: <fpage>641</fpage>–647.<pub-id pub-id-type="pmid">20808231</pub-id></mixed-citation>
</ref>
<ref id="bib31">
<mixed-citation publication-type="journal">Sampson MG, Coughlin CR, Kaplan P, Conlin LK, Meyers KE, Zackai EH et al. <article-title>Evidence for a recurrent microdeletion at chromosome 16p11.2 associated with
congenital anomalies of the kidney and urinary tract (CAKUT) and Hirschsprung
disease</article-title>. <source/>Am J Med Genet A
<year>2010</year>; <volume>152A</volume>: <fpage>2618</fpage>–2622.<pub-id pub-id-type="pmid">20799338</pub-id></mixed-citation>
</ref>
<ref id="bib32">
<mixed-citation publication-type="journal">Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A et al. <article-title>Phenotypic heterogeneity of genomic disorders and rare copy-number
variants</article-title>. <source/>N Engl J Med
<year>2012</year>; <volume>367</volume>: <fpage>1321</fpage>–1331.<pub-id pub-id-type="pmid">22970919</pub-id></mixed-citation>
</ref>
<ref id="bib33">
<mixed-citation publication-type="journal">Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C et al. <article-title>A copy number variation morbidity map of developmental delay</article-title>. <source/>Nat Genet
<year>2011</year>; <volume>43</volume>: <fpage>838</fpage>–846.<pub-id pub-id-type="pmid">21841781</pub-id></mixed-citation>
</ref>
<ref id="bib34">
<mixed-citation publication-type="journal">Bijlsma EK, Gijsbers AC, Schuurs-Hoeijmakers JH, van Haeringen A, Fransen van de Putte DE, Anderlid BM et al. <article-title>Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in
mentally retarded patients without autism and in normal individuals</article-title>. <source/>Eur J Med Genet
<year>2009</year>; <volume>52</volume>: <fpage>77</fpage>–87.<pub-id pub-id-type="pmid">19306953</pub-id></mixed-citation>
</ref>
<ref id="bib35">
<mixed-citation publication-type="journal">Guha S, Rees E, Darvasi A, Ivanov D, Ikeda M, Bergen SE et al. <article-title>Implication of a rare deletion at distal 16p11.2 in schizophrenia</article-title>. <source/>JAMA Psychiatry
<year>2013</year>; <volume>70</volume>: <fpage>253</fpage>–260.<pub-id pub-id-type="pmid">23325106</pub-id></mixed-citation>
</ref>
<ref id="bib36">
<mixed-citation publication-type="journal">Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, Brodsky J et al. <article-title>Genome-wide association analysis of metabolic traits in a birth cohort from a
founder population</article-title>. <source/>Nat Genet
<year>2009</year>; <volume>41</volume>: <fpage>35</fpage>–46.<pub-id pub-id-type="pmid">19060910</pub-id></mixed-citation>
</ref>
<ref id="bib37">
<mixed-citation publication-type="journal">Nelis M, Esko T, Magi R, Zimprich F, Zimprich A, Toncheva D et al. <article-title>Genetic structure of Europeans: a view from the North-East</article-title>. <source/>PLoS One
<year>2009</year>; <volume>4</volume>: <fpage>e5472</fpage>.<pub-id pub-id-type="pmid">19424496</pub-id></mixed-citation>
</ref>
<ref id="bib38">
<mixed-citation publication-type="journal">John U, Greiner B, Hensel E, Ludemann J, Piek M, Sauer S et al. <article-title>Study of Health In Pomerania (SHIP): a health examination survey in an east
German region: objectives and design</article-title>. <source/>Soz Praventivmed
<year>2001</year>; <volume>46</volume>: <fpage>186</fpage>–194.<pub-id pub-id-type="pmid">11565448</pub-id></mixed-citation>
</ref>
<ref id="bib39">
<mixed-citation publication-type="journal">Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D et al. <article-title>The CoLaus study: a population-based study to investigate the epidemiology and
genetic determinants of cardiovascular risk factors and metabolic syndrome</article-title>. <source/>BMC Cardiovasc Disord
<year>2008</year>; <volume>8</volume>: <fpage>6</fpage>.<pub-id pub-id-type="pmid">18366642</pub-id></mixed-citation>
</ref>
<ref id="bib40">
<mixed-citation publication-type="journal">Chabchoub E, Willekens D, Vermeesch JR, Fryns JP. <article-title>Holoprosencephaly and ZIC2 microdeletions: novel clinical and epidemiological
specificities delineated</article-title>. <source/>Clin Genet
<year>2012</year>; <volume>81</volume>: <fpage>584</fpage>–589.<pub-id pub-id-type="pmid">21496007</pub-id></mixed-citation>
</ref>
<ref id="bib41">
<mixed-citation publication-type="journal">de Leeuw N, Pfundt R, Koolen DA, Neefs I, Scheltinga I, Mieloo H et al. <article-title>A newly recognised microdeletion syndrome involving 2p15p16.1: narrowing down
the critical region by adding another patient detected by genome wide tiling path
array comparative genomic hybridisation analysis</article-title>. <source/>J Med Genet
<year>2008</year>; <volume>45</volume>: <fpage>122</fpage>–124.<pub-id pub-id-type="pmid">18245392</pub-id></mixed-citation>
</ref>
<ref id="bib42">
<mixed-citation publication-type="journal">Felix TM, Petrin AL, Sanseverino MT, Murray JC. <article-title>Further characterization of microdeletion syndrome involving 2p15-p16.1</article-title>. <source/>Am J Med Genet A
<year>2010</year>; <volume>152A</volume>: <fpage>2604</fpage>–2608.<pub-id pub-id-type="pmid">20799320</pub-id></mixed-citation>
</ref>
<ref id="bib43">
<mixed-citation publication-type="journal">Florisson JM, Mathijssen IM, Dumee B, Hoogeboom JA, Poddighe PJ, Oostra BA et al. <article-title>Complex craniosynostosis is associated with the 2p15p16.1 microdeletion
syndrome</article-title>. <source/>Am J Med Genet A
<year>2013</year>; <volume>161A</volume>: <fpage>244</fpage>–253.<pub-id pub-id-type="pmid">23303641</pub-id></mixed-citation>
</ref>
<ref id="bib44">
<mixed-citation publication-type="journal">Hancarova M, Vejvalkova S, Trkova M, Drabova J, Dleskova A, Vlckova M et al. <article-title>Identification of a patient with intellectual disability and de novo 3.7 Mb
deletion supports the existence of a novel microdeletion syndrome in
2p14-p15</article-title>. <source/>Gene
<year>2013</year>; <volume>516</volume>: <fpage>158</fpage>–161.<pub-id pub-id-type="pmid">23266801</pub-id></mixed-citation>
</ref>
<ref id="bib45">
<mixed-citation publication-type="journal">Hucthagowder V, Liu TC, Paciorkowski AR, Thio LL, Keller MS, Anderson CD et al. <article-title>Chromosome 2p15p16.1 microdeletion syndrome: 2.5 Mb deletion in a patient with
renal anomalies, intractable seizures and a choledochal cyst</article-title>. <source/>Eur J Med Genet
<year>2012</year>; <volume>55</volume>: <fpage>485</fpage>–489.<pub-id pub-id-type="pmid">22579565</pub-id></mixed-citation>
</ref>
<ref id="bib46">
<mixed-citation publication-type="journal">Liang JS, Shimojima K, Ohno K, Sugiura C, Une Y, Ohno K et al. <article-title>A newly recognised microdeletion syndrome of 2p15-16.1 manifesting moderate
developmental delay, autistic behaviour, short stature, microcephaly, and dysmorphic
features: a new patient with 3.2 Mb deletion</article-title>. <source/>J Med Genet
<year>2009</year>; <volume>46</volume>: <fpage>645</fpage>–647.<pub-id pub-id-type="pmid">19724011</pub-id></mixed-citation>
</ref>
<ref id="bib47">
<mixed-citation publication-type="journal">Piccione M, Piro E, Serraino F, Cavani S, Ciccone R, Malacarne M et al. <article-title>Interstitial deletion of chromosome 2p15-16.1: report of two patients and
critical review of current genotype-phenotype correlation</article-title>. <source/>Eur J Med Genet
<year>2012</year>; <volume>55</volume>: <fpage>238</fpage>–244.<pub-id pub-id-type="pmid">22406401</pub-id></mixed-citation>
</ref>
<ref id="bib48">
<mixed-citation publication-type="journal">Prontera P, Bernardini L, Stangoni G, Capalbo A, Rogaia D, Romani R et al. <article-title>Deletion 2p15-16.1 syndrome: case report and review</article-title>. <source/>Am J Med Genet A
<year>2011</year>; <volume>155A</volume>: <fpage>2473</fpage>–2478.<pub-id pub-id-type="pmid">21910216</pub-id></mixed-citation>
</ref>
<ref id="bib49">
<mixed-citation publication-type="journal">Rajcan-Separovic E, Harvard C, Liu X, McGillivray B, Hall JG, Qiao Y et al. <article-title>Clinical and molecular cytogenetic characterisation of a newly recognised
microdeletion syndrome involving 2p15-16.1</article-title>. <source/>J Med Genet
<year>2007</year>; <volume>44</volume>: <fpage>269</fpage>–276.<pub-id pub-id-type="pmid">16963482</pub-id></mixed-citation>
</ref>
<ref id="bib50">
<mixed-citation publication-type="journal">Jorgez CJ, Rosenfeld JA, Wilken NR, Vangapandu HV, Sahin A, Pham D et al. <article-title>Genitourinary defects associated with genomic deletions in 2p15 encompassing
OTX1</article-title>. <source/>PLoS One
<year>2014</year>; <volume>9</volume>: <fpage>e107028</fpage>.<pub-id pub-id-type="pmid">25203062</pub-id></mixed-citation>
</ref>
<ref id="bib51">
<mixed-citation publication-type="journal">Simonis M, Klous P, Splinter E, Moshkin Y, Willemsen R, de Wit E et al. <article-title>Nuclear organization of active and inactive chromatin domains uncovered by
chromosome conformation capture-on-chip (4C)</article-title>. <source/>Nat Genet
<year>2006</year>; <volume>38</volume>: <fpage>1348</fpage>–1354.<pub-id pub-id-type="pmid">17033623</pub-id></mixed-citation>
</ref>
<ref id="bib52">
<mixed-citation publication-type="journal">Simonis M, Kooren J, de Laat W. <article-title>An evaluation of 3C-based methods to capture DNA interactions</article-title>. <source/>Nat Methods
<year>2007</year>; <volume>4</volume>: <fpage>895</fpage>–901.<pub-id pub-id-type="pmid">17971780</pub-id></mixed-citation>
</ref>
<ref id="bib53">
<mixed-citation publication-type="journal">Noordermeer D, Leleu M, Splinter E, Rougemont J, De Laat W, Duboule D. <article-title>The dynamic architecture of Hox gene clusters</article-title>. <source/>Science
<year>2011</year>; <volume>334</volume>: <fpage>222</fpage>–225.<pub-id pub-id-type="pmid">21998387</pub-id></mixed-citation>
</ref>
<ref id="bib54">
<mixed-citation publication-type="journal">Gheldof N, Leleu M, Noordermeer D, Rougemont J, Reymond A. <article-title>Detecting long-range chromatin interactions using the chromosome conformation
capture sequencing (4C-seq) method</article-title>. <source/>Methods Mol Biol
<year>2012</year>; <volume>786</volume>: <fpage>211</fpage>–225.<pub-id pub-id-type="pmid">21938629</pub-id></mixed-citation>
</ref>
<ref id="bib55">
<mixed-citation publication-type="journal">Blaker-Lee A, Gupta S, McCammon JM, De Rienzo G, Sive H. <article-title>Zebrafish homologs of genes within 16p11.2, a genomic region associated with
brain disorders, are active during brain development, and include two deletion dosage
sensor genes</article-title>. <source/>Dis Models Mech
<year>2012</year>; <volume>5</volume>: <fpage>834</fpage>–851.</mixed-citation>
</ref>
<ref id="bib56">
<mixed-citation publication-type="journal">Kishi H, Mukai T, Hirono A, Fujii H, Miwa S, Hori K. <article-title>Human aldolase A deficiency associated with a hemolytic anemia: thermolabile
aldolase due to a single base mutation</article-title>. <source/>Proc Natl Acad Sci USA
<year>1987</year>; <volume>84</volume>: <fpage>8623</fpage>–8627.<pub-id pub-id-type="pmid">2825199</pub-id></mixed-citation>
</ref>
<ref id="bib57">
<mixed-citation publication-type="journal">Watabe-Rudolph M, Schlautmann N, Papaioannou VE, Gossler A. <article-title>The mouse rib-vertebrae mutation is a hypomorphic Tbx6 allele</article-title>. <source/>Mech Dev
<year>2002</year>; <volume>119</volume>: <fpage>251</fpage>–256.<pub-id pub-id-type="pmid">12464437</pub-id></mixed-citation>
</ref>
<ref id="bib58">
<mixed-citation publication-type="journal">Fei Q, Wu Z, Wang H, Zhou X, Wang N, Ding Y et al. <article-title>The association analysis of TBX6 polymorphism with susceptibility to congenital
scoliosis in a Chinese Han population</article-title>. <source/>Spine
<year>2010</year>; <volume>35</volume>: <fpage>983</fpage>–988.<pub-id pub-id-type="pmid">20228709</pub-id></mixed-citation>
</ref>
<ref id="bib59">
<mixed-citation publication-type="journal">Sparrow DB, McInerney-Leo A, Gucev ZS, Gardiner B, Marshall M, Leo PJ et al. <article-title>Autosomal dominant spondylocostal dysostosis is caused by mutation in
TBX6</article-title>. <source/>Hum Mol Genet
<year>2013</year>; <volume>22</volume>: <fpage>1625</fpage>–1631.<pub-id pub-id-type="pmid">23335591</pub-id></mixed-citation>
</ref>
<ref id="bib60">
<mixed-citation publication-type="journal">Wu N, Ming X, Xiao J, Wu Z, Chen X, Shinawi M et al. <article-title>TBX6 null variants and a common hypomorphic allele in congenital
scoliosis</article-title>. <source/>N Engl J Med
<year>2015</year>; <volume>372</volume>: <fpage>341</fpage>–350.<pub-id pub-id-type="pmid">25564734</pub-id></mixed-citation>
</ref>
<ref id="bib61">
<mixed-citation publication-type="journal">Duan C, Li M, Rui L. <article-title>SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation
of the phosphatidylinositol 3-kinase pathway in response to leptin</article-title>. <source/>J Biol Chem
<year>2004</year>; <volume>279</volume>: <fpage>43684</fpage>–43691.<pub-id pub-id-type="pmid">15316008</pub-id></mixed-citation>
</ref>
<ref id="bib62">
<mixed-citation publication-type="journal">Ren D, Zhou Y, Morris D, Li M, Li Z, Rui L. <article-title>Neuronal SH2B1 is essential for controlling energy and glucose
homeostasis</article-title>. <source/>J Clin Invest
<year>2007</year>; <volume>117</volume>: <fpage>397</fpage>–406.<pub-id pub-id-type="pmid">17235396</pub-id></mixed-citation>
</ref>
<ref id="bib63">
<mixed-citation publication-type="journal">Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM et al. <article-title>Six new loci associated with body mass index highlight a neuronal influence on
body weight regulation</article-title>. <source/>Nat Genet
<year>2009</year>; <volume>41</volume>: <fpage>25</fpage>–34.<pub-id pub-id-type="pmid">19079261</pub-id></mixed-citation>
</ref>
<ref id="bib64">
<mixed-citation publication-type="journal">Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A et al. <article-title>Genome-wide association yields new sequence variants at seven loci that
associate with measures of obesity</article-title>. <source/>Nat Genet
<year>2009</year>; <volume>41</volume>: <fpage>18</fpage>–24.<pub-id pub-id-type="pmid">19079260</pub-id></mixed-citation>
</ref>
<ref id="bib65">
<mixed-citation publication-type="journal">Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU et al. <article-title>Association analyses of 249,796 individuals reveal 18 new loci associated with
body mass index</article-title>. <source/>Nat Genet
<year>2010</year>; <volume>42</volume>: <fpage>937</fpage>–948.<pub-id pub-id-type="pmid">20935630</pub-id></mixed-citation>
</ref>
<ref id="bib66">
<mixed-citation publication-type="journal">Jamshidi Y, Snieder H, Ge D, Spector TD, O'Dell SD. <article-title>The SH2B gene is associated with serum leptin and body fat in normal female
twins</article-title>. <source/>Obesity (Silver Spring)
<year>2007</year>; <volume>15</volume>: <fpage>5</fpage>–9.<pub-id pub-id-type="pmid">17228025</pub-id></mixed-citation>
</ref>
<ref id="bib67">
<mixed-citation publication-type="journal">Doche ME, Bochukova EG, Su HW, Pearce LR, Keogh JM, Henning E et al. <article-title>Human SH2B1 mutations are associated with maladaptive behaviors and
obesity</article-title>. <source/>J Clin Invest
<year>2012</year>; <volume>122</volume>: <fpage>4732</fpage>–4736.<pub-id pub-id-type="pmid">23160192</pub-id></mixed-citation>
</ref>
<ref id="bib68">
<mixed-citation publication-type="journal">Fuller DM, Zhu M, Ou-Yang CW, Sullivan SA, Zhang W. <article-title>A tale of two TRAPs: LAT and LAB in the regulation of lymphocyte development,
activation, and autoimmunity</article-title>. <source/>Immunol Res
<year>2011</year>; <volume>49</volume>: <fpage>97</fpage>–108.<pub-id pub-id-type="pmid">21136199</pub-id></mixed-citation>
</ref>
<ref id="bib69">
<mixed-citation publication-type="journal">Shim EK, Jung SH, Lee JR. <article-title>Role of two adaptor molecules SLP-76 and LAT in the PI3K signaling pathway in
activated T cells</article-title>. <source/>J Immunol
<year>2011</year>; <volume>186</volume>: <fpage>2926</fpage>–2935.<pub-id pub-id-type="pmid">21282515</pub-id></mixed-citation>
</ref>
<ref id="bib70">
<mixed-citation publication-type="journal">Fuller DM, Zhu M, Koonpaew S, Nelson MI, Zhang W. <article-title>The importance of the Erk pathway in the development of linker for activation of
T cells-mediated autoimmunity</article-title>. <source/>J Immunol
<year>2012</year>; <volume>189</volume>: <fpage>4005</fpage>–4013.<pub-id pub-id-type="pmid">22984075</pub-id></mixed-citation>
</ref>
<ref id="bib71">
<mixed-citation publication-type="journal">David FP, Delafontaine J, Carat S, Ross FJ, Lefebvre G, Jarosz Y et al. <article-title>HTSstation: a web application and open-access libraries for high-throughput
sequencing data analysis</article-title>. <source/>PLoS One
<year>2014</year>; <volume>9</volume>: <fpage>e85879</fpage>.<pub-id pub-id-type="pmid">24475057</pub-id></mixed-citation>
</ref>
<ref id="bib72">
<mixed-citation publication-type="journal">Tolhuis B, Blom M, Kerkhoven RM, Pagie L, Teunissen H, Nieuwland M et al. <article-title>Interactions among Polycomb domains are guided by chromosome
architecture</article-title>. <source/>PLoS Genet
<year>2011</year>; <volume>7</volume>: <fpage>e1001343</fpage>.<pub-id pub-id-type="pmid">21455484</pub-id></mixed-citation>
</ref>
<ref id="bib73">
<mixed-citation publication-type="journal">Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A et al. <article-title>Comprehensive mapping of long-range interactions reveals folding principles of
the human genome</article-title>. <source/>Science
<year>2009</year>; <volume>326</volume>: <fpage>289</fpage>–293.<pub-id pub-id-type="pmid">19815776</pub-id></mixed-citation>
</ref>
<ref id="bib74">
<mixed-citation publication-type="journal">de Wit E, Braunschweig U, Greil F, Bussemaker HJ, van Steensel B. <article-title>Global chromatin domain organization of the Drosophila genome</article-title>. <source/>PLoS Genet
<year>2008</year>; <volume>4</volume>: <fpage>e1000045</fpage>.<pub-id pub-id-type="pmid">18369463</pub-id></mixed-citation>
</ref>
<ref id="bib75">
<mixed-citation publication-type="journal">Rao SS, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT et al. <article-title>A 3D map of the human genome at kilobase resolution reveals principles of
chromatin looping</article-title>. <source/>Cell
<year>2014</year>; <volume>159</volume>: <fpage>1665</fpage>–1680.<pub-id pub-id-type="pmid">25497547</pub-id></mixed-citation>
</ref>
<ref id="bib76">
<mixed-citation publication-type="journal">Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A et al. <article-title>STRING v9.1: protein-protein interaction networks, with increased coverage and
integration</article-title>. <source/>Nucleic Acids Res
<year>2013</year>; <volume>41</volume>: <fpage>D808</fpage>–D815.<pub-id pub-id-type="pmid">23203871</pub-id></mixed-citation>
</ref>
<ref id="bib77">
<mixed-citation publication-type="other">Alexa A, Rahnenfuhrer J. topGO: Enrichment analysis for Gene Ontology. BioConductor, <year>2010</year>.</mixed-citation>
</ref>
<ref id="bib78">
<mixed-citation publication-type="journal">da Huang W, Sherman BT, Lempicki RA. <article-title>Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources</article-title>. <source/>Nat Protoc
<year>2009</year>; <volume>4</volume>: <fpage>44</fpage>–57.<pub-id pub-id-type="pmid">19131956</pub-id></mixed-citation>
</ref>
<ref id="bib79">
<mixed-citation publication-type="journal">Reimand J, Arak T, Vilo J. <article-title>g:Profiler—a web server for functional interpretation of gene lists (2011
update)</article-title>. <source/>Nucleic Acids Res
<year>2011</year>; <volume>39</volume>: <fpage>W307</fpage>–W315.<pub-id pub-id-type="pmid">21646343</pub-id></mixed-citation>
</ref>
<ref id="bib80">
<mixed-citation publication-type="journal">Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV et al. <article-title>Enrichr: interactive and collaborative HTML5 gene list enrichment analysis
tool</article-title>. <source/>BMC Bioinformatics
<year>2013</year>; <volume>14</volume>: <fpage>128</fpage>.<pub-id pub-id-type="pmid">23586463</pub-id></mixed-citation>
</ref>
<ref id="bib81">
<mixed-citation publication-type="journal">Hamosh A, Scott AF, Amberger J, Valle D, McKusick VA. <article-title>Online Mendelian Inheritance in Man (OMIM)</article-title>. <source/>Hum Mutat
<year>2000</year>; <volume>15</volume>: <fpage>57</fpage>–61.<pub-id pub-id-type="pmid">10612823</pub-id></mixed-citation>
</ref>
<ref id="bib82">
<mixed-citation publication-type="journal">Girard SL, Gauthier J, Noreau A, Xiong L, Zhou S, Jouan L et al. <article-title>Increased exonic de novo mutation rate in individuals with
schizophrenia</article-title>. <source/>Nat Genet
<year>2011</year>; <volume>43</volume>: <fpage>860</fpage>–863.<pub-id pub-id-type="pmid">21743468</pub-id></mixed-citation>
</ref>
<ref id="bib83">
<mixed-citation publication-type="journal">Xu B, Ionita-Laza I, Roos JL, Boone B, Woodrick S, Sun Y et al. <article-title>De novo gene mutations highlight patterns of genetic and neural complexity in
schizophrenia</article-title>. <source/>Nat Genet
<year>2012</year>; <volume>44</volume>: <fpage>1365</fpage>–1369.<pub-id pub-id-type="pmid">23042115</pub-id></mixed-citation>
</ref>
<ref id="bib84">
<mixed-citation publication-type="journal">Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S et al. <article-title>Exome sequencing supports a de novo mutational paradigm for
schizophrenia</article-title>. <source/>Nat Genet
<year>2011</year>; <volume>43</volume>: <fpage>864</fpage>–868.<pub-id pub-id-type="pmid">21822266</pub-id></mixed-citation>
</ref>
<ref id="bib85">
<mixed-citation publication-type="journal">Vimaleswaran KS, Tachmazidou I, Zhao JH, Hirschhorn JN, Dudbridge F, Loos RJ. <article-title>Candidate genes for obesity-susceptibility show enriched association within a
large genome-wide association study for BMI</article-title>. <source/>Hum Mol Genet
<year>2012</year>; <volume>21</volume>: <fpage>4537</fpage>–4542.<pub-id pub-id-type="pmid">22791748</pub-id></mixed-citation>
</ref>
<ref id="bib86">
<mixed-citation publication-type="journal">De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Ercument Cicek A et al. <article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>. <source/>Nature
<year>2014</year>; <volume>515</volume>: <fpage>209</fpage>–215.<pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
</ref>
<ref id="bib87">
<mixed-citation publication-type="journal">Iossifov I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D et al. <article-title>The contribution of de novo coding mutations to autism spectrum
disorder</article-title>. <source/>Nature
<year>2014</year>; <volume>515</volume>: <fpage>216</fpage>–221.<pub-id pub-id-type="pmid">25363768</pub-id></mixed-citation>
</ref>
<ref id="bib88">
<mixed-citation publication-type="journal">van Dam TJ, Wheway G, Slaats GG, Group SS, Huynen MA, Giles RH. <article-title>The SYSCILIA gold standard (SCGSv1) of known ciliary components and its
applications within a systems biology consortium</article-title>. <source/>Cilia
<year>2013</year>; <volume>2</volume>: <fpage>7</fpage>.<pub-id pub-id-type="pmid">23725226</pub-id></mixed-citation>
</ref>
<ref id="bib89">
<mixed-citation publication-type="journal">Stehbens S, Wittmann T. <article-title>Targeting and transport: how microtubules control focal adhesion
dynamics</article-title>. <source/>J Cell Biol
<year>2012</year>; <volume>198</volume>: <fpage>481</fpage>–489.<pub-id pub-id-type="pmid">22908306</pub-id></mixed-citation>
</ref>
<ref id="bib90">
<mixed-citation publication-type="journal">Bukoreshtliev NV, Haase K, Pelling AE. <article-title>Mechanical cues in cellular signalling and communication</article-title>. <source/>Cell Tissue Res
<year>2013</year>; <volume>352</volume>: <fpage>77</fpage>–94.<pub-id pub-id-type="pmid">23224763</pub-id></mixed-citation>
</ref>
<ref id="bib91">
<mixed-citation publication-type="journal">Seeger-Nukpezah T, Golemis EA. <article-title>The extracellular matrix and ciliary signaling</article-title>. <source/>Curr Opin Cell Biol
<year>2012</year>; <volume>24</volume>: <fpage>652</fpage>–661.<pub-id pub-id-type="pmid">22819513</pub-id></mixed-citation>
</ref>
<ref id="bib92">
<mixed-citation publication-type="journal">He G, Liu X, Qin W, Chen Q, Wang X, Yang Y et al. <article-title>MPZL1/PZR, a novel candidate predisposing schizophrenia in Han
Chinese</article-title>. <source/>Mol Psychiatry
<year>2006</year>; <volume>11</volume>: <fpage>748</fpage>–751.<pub-id pub-id-type="pmid">16702974</pub-id></mixed-citation>
</ref>
<ref id="bib93">
<mixed-citation publication-type="journal">Eminaga S, Bennett AM. <article-title>Noonan syndrome-associated SHP-2/Ptpn11 mutants enhance SIRPalpha and PZR
tyrosyl phosphorylation and promote adhesion-mediated ERK activation</article-title>. <source/>J Biol Chem
<year>2008</year>; <volume>283</volume>: <fpage>15328</fpage>–15338.<pub-id pub-id-type="pmid">18378677</pub-id></mixed-citation>
</ref>
<ref id="bib94">
<mixed-citation publication-type="journal">Lichter P, Tang CJ, Call K, Hermanson G, Evans GA, Housman D et al. <article-title>High-resolution mapping of human chromosome 11 by in situ hybridization with
cosmid clones</article-title>. <source/>Science
<year>1990</year>; <volume>247</volume>: <fpage>64</fpage>–69.<pub-id pub-id-type="pmid">2294592</pub-id></mixed-citation>
</ref>
<ref id="bib95">
<mixed-citation publication-type="journal">Waszak SM, Delaneau O, Gschwind AR, Kilpinen H, Raghav SK, Witwicki RM et al. <article-title>Population variation and genetic control of modular chromatin architecture in
humans</article-title>. <source/>Cell
<year>2015</year>; <volume>162</volume>: <fpage>1039</fpage>–1050.<pub-id pub-id-type="pmid">26300124</pub-id></mixed-citation>
</ref>
<ref id="bib96">
<mixed-citation publication-type="journal">Genomes Project C, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM et al. <article-title>A map of human genome variation from population-scale sequencing</article-title>. <source/>Nature
<year>2010</year>; <volume>467</volume>: <fpage>1061</fpage>–1073.<pub-id pub-id-type="pmid">20981092</pub-id></mixed-citation>
</ref>
<ref id="bib97">
<mixed-citation publication-type="journal">Kilpinen H, Waszak SM, Gschwind AR, Raghav SK, Witwicki RM, Orioli A et al. <article-title>Coordinated effects of sequence variation on DNA binding, chromatin structure,
and transcription</article-title>. <source/>Science
<year>2013</year>; <volume>342</volume>: <fpage>744</fpage>–747.<pub-id pub-id-type="pmid">24136355</pub-id></mixed-citation>
</ref>
<ref id="bib98">
<mixed-citation publication-type="journal">Lappalainen T, Sammeth M, Friedlander MR, t Hoen PA, Monlong J, Rivas MA et al. <article-title>Transcriptome and genome sequencing uncovers functional variation in
humans</article-title>. <source/>Nature
<year>2013</year>; <volume>501</volume>: <fpage>506</fpage>–511.<pub-id pub-id-type="pmid">24037378</pub-id></mixed-citation>
</ref>
<ref id="bib99">
<mixed-citation publication-type="journal">CDC. <article-title>Prevalence of autism spectrum disorder among children aged 8 years —
autism and developmental disabilities monitoring network, 11 sites, United States,
2010</article-title>. <source/>MMWR Surveill Summ
<year>2014</year>; <volume>63</volume>: <fpage>1</fpage>–21.</mixed-citation>
</ref>
<ref id="bib100">
<mixed-citation publication-type="journal">Gheldof N, Witwicki RM, Migliavacca E, Leleu M, Didelot G, Harewood L et al. <article-title>Structural variation-associated expression changes are paralleled by chromatin
architecture modifications</article-title>. <source/>PLoS One
<year>2013</year>; <volume>8</volume>: <fpage>e79973</fpage>.<pub-id pub-id-type="pmid">24265791</pub-id></mixed-citation>
</ref>
<ref id="bib101">
<mixed-citation publication-type="journal">Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y et al. <article-title>Topological domains in mammalian genomes identified by analysis of chromatin
interactions</article-title>. <source/>Nature
<year>2012</year>; <volume>485</volume>: <fpage>376</fpage>–380.<pub-id pub-id-type="pmid">22495300</pub-id></mixed-citation>
</ref>
<ref id="bib102">
<mixed-citation publication-type="journal">Zhang Y, Wong CH, Birnbaum RY, Li G, Favaro R, Ngan CY et al. <article-title>Chromatin connectivity maps reveal dynamic promoter-enhancer long-range
associations</article-title>. <source/>Nature
<year>2013</year>; <volume>504</volume>: <fpage>306</fpage>–310.<pub-id pub-id-type="pmid">24213634</pub-id></mixed-citation>
</ref>
<ref id="bib103">
<mixed-citation publication-type="journal">Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN et al. <article-title>Subset of individuals with autism spectrum disorders and extreme macrocephaly
associated with germline PTEN tumour suppressor gene mutations</article-title>. <source/>J Med Genet
<year>2005</year>; <volume>42</volume>: <fpage>318</fpage>–321.<pub-id pub-id-type="pmid">15805158</pub-id></mixed-citation>
</ref>
<ref id="bib104">
<mixed-citation publication-type="journal">Herman GE, Butter E, Enrile B, Pastore M, Prior TW, Sommer A. <article-title>Increasing knowledge of PTEN germline mutations: two additional patients with
autism and macrocephaly</article-title>. <source/>Am J Med Genet A
<year>2007</year>; <volume>143</volume>: <fpage>589</fpage>–593.</mixed-citation>
</ref>
<ref id="bib105">
<mixed-citation publication-type="journal">O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG et al. <article-title>Multiplex targeted sequencing identifies recurrently mutated genes in autism
spectrum disorders</article-title>. <source/>Science
<year>2012</year>; <volume>338</volume>: <fpage>1619</fpage>–1622.<pub-id pub-id-type="pmid">23160955</pub-id></mixed-citation>
</ref>
<ref id="bib106">
<mixed-citation publication-type="journal">Pal A, Barber TM, Van de Bunt M, Rudge SA, Zhang Q, Lachlan KL et al. <article-title>PTEN mutations as a cause of constitutive insulin sensitivity and
obesity</article-title>. <source/>N Engl J Med
<year>2012</year>; <volume>367</volume>: <fpage>1002</fpage>–1011.<pub-id pub-id-type="pmid">22970944</pub-id></mixed-citation>
</ref>
<ref id="bib107">
<mixed-citation publication-type="journal">Girirajan S, Dennis MY, Baker C, Malig M, Coe BP, Campbell CD et al. <article-title>Refinement and discovery of new hotspots of copy-number variation associated
with autism spectrum disorder</article-title>. <source/>Am J Hum Genet
<year>2013</year>; <volume>92</volume>: <fpage>221</fpage>–237.<pub-id pub-id-type="pmid">23375656</pub-id></mixed-citation>
</ref>
<ref id="bib108">
<mixed-citation publication-type="journal">Harvard C, Strong E, Mercier E, Colnaghi R, Alcantara D, Chow E et al. <article-title>Understanding the impact of 1q21.1 copy number variant</article-title>. <source/>Orphanet J Rare Dis
<year>2011</year>; <volume>6</volume>: <fpage>54</fpage>.<pub-id pub-id-type="pmid">21824431</pub-id></mixed-citation>
</ref>
<ref id="bib109">
<mixed-citation publication-type="journal">Brunetti-Pierri N, Berg JS, Scaglia F, Belmont J, Bacino CA, Sahoo T et al. <article-title>Recurrent reciprocal 1q21.1 deletions and duplications associated with
microcephaly or macrocephaly and developmental and behavioral abnormalities</article-title>. <source/>Nat Genet
<year>2008</year>; <volume>40</volume>: <fpage>1466</fpage>–1471.<pub-id pub-id-type="pmid">19029900</pub-id></mixed-citation>
</ref>
<ref id="bib110">
<mixed-citation publication-type="journal">Griswold AJ, Ma D, Cukier HN, Nations LD, Schmidt MA, Chung RH et al. <article-title>Evaluation of copy number variations reveals novel candidate genes in autism
spectrum disorder-associated pathways</article-title>. <source/>Hum Mol Genet
<year>2012</year>; <volume>21</volume>: <fpage>3513</fpage>–3523.<pub-id pub-id-type="pmid">22543975</pub-id></mixed-citation>
</ref>
<ref id="bib111">
<mixed-citation publication-type="journal">Liu X, Malenfant P, Reesor C, Lee A, Hudson ML, Harvard C et al. <article-title>2p15-p16.1 microdeletion syndrome: molecular characterization and association of
the OTX1 and XPO1 genes with autism spectrum disorders</article-title>. <source/>Eur J Hum Genet
<year>2011</year>; <volume>19</volume>: <fpage>1264</fpage>–1270.<pub-id pub-id-type="pmid">21750575</pub-id></mixed-citation>
</ref>
<ref id="bib112">
<mixed-citation publication-type="journal">Fannemel M, Baroy T, Holmgren A, Rodningen OK, Haugsand TM, Hansen B et al. <article-title>Haploinsufficiency of XPO1 and USP34 by a de novo 230 kb deletion in 2p15, in a
patient with mild intellectual disability and cranio-facial dysmorphisms</article-title>. <source/>Eur J Med Genet
<year>2014</year>; <volume>57</volume>: <fpage>513</fpage>–519.<pub-id pub-id-type="pmid">24911659</pub-id></mixed-citation>
</ref>
<ref id="bib113">
<mixed-citation publication-type="journal">Vaags AK, Lionel AC, Sato D, Goodenberger M, Stein QP, Curran S et al. <article-title>Rare deletions at the neurexin 3 locus in autism spectrum disorder</article-title>. <source/>Am J Hum Genet
<year>2012</year>; <volume>90</volume>: <fpage>133</fpage>–141.<pub-id pub-id-type="pmid">22209245</pub-id></mixed-citation>
</ref>
<ref id="bib114">
<mixed-citation publication-type="journal">Seltzer LE, Paciorkowski AR. <article-title>Genetic disorders associated with postnatal microcephaly</article-title>. <source/>Am J Med Genet C Semin Med Genet
<year>2014</year>; <volume>166</volume>: <fpage>140</fpage>–155.</mixed-citation>
</ref>
<ref id="bib115">
<mixed-citation publication-type="journal">Bjursell MK, Blom HJ, Cayuela JA, Engvall ML, Lesko N, Balasubramaniam S et al. <article-title>Adenosine kinase deficiency disrupts the methionine cycle and causes
hypermethioninemia, encephalopathy, and abnormal liver function</article-title>. <source/>Am J Hum Genet
<year>2011</year>; <volume>89</volume>: <fpage>507</fpage>–515.<pub-id pub-id-type="pmid">21963049</pub-id></mixed-citation>
</ref>
<ref id="bib116">
<mixed-citation publication-type="journal">Doornbos M, Sikkema-Raddatz B, Ruijvenkamp CA, Dijkhuizen T, Bijlsma EK, Gijsbers AC et al. <article-title>Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the
Prader-Willi critical region, possibly associated with behavioural
disturbances</article-title>. <source/>Eur J Med Genet
<year>2009</year>; <volume>52</volume>: <fpage>108</fpage>–115.<pub-id pub-id-type="pmid">19328872</pub-id></mixed-citation>
</ref>
<ref id="bib117">
<mixed-citation publication-type="journal">Kolehmainen J, Wilkinson R, Lehesjoki AE, Chandler K, Kivitie-Kallio S, Clayton-Smith J et al. <article-title>Delineation of Cohen syndrome following a large-scale genotype-phenotype
screen</article-title>. <source/>Am J Hum Genet
<year>2004</year>; <volume>75</volume>: <fpage>122</fpage>–127.<pub-id pub-id-type="pmid">15141358</pub-id></mixed-citation>
</ref>
<ref id="bib118">
<mixed-citation publication-type="journal">Chung JH, Eng C. <article-title>Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on
chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis</article-title>. <source/>Cancer Res
<year>2005</year>; <volume>65</volume>: <fpage>8096</fpage>–8100.<pub-id pub-id-type="pmid">16166282</pub-id></mixed-citation>
</ref>
<ref id="bib119">
<mixed-citation publication-type="journal">Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W et al. <article-title>Pten regulates neuronal arborization and social interaction in mice</article-title>. <source/>Neuron
<year>2006</year>; <volume>50</volume>: <fpage>377</fpage>–388.<pub-id pub-id-type="pmid">16675393</pub-id></mixed-citation>
</ref>
<ref id="bib120">
<mixed-citation publication-type="journal">Adviento B, Corbin IL, Widjaja F, Desachy G, Enrique N, Rosser T et al. <article-title>Autism traits in the RASopathies</article-title>. <source/>J Med Genet
<year>2014</year>; <volume>51</volume>: <fpage>10</fpage>–20.<pub-id pub-id-type="pmid">24101678</pub-id></mixed-citation>
</ref>
<ref id="bib121">
<mixed-citation publication-type="journal">Alfieri P, Piccini G, Caciolo C, Perrino F, Gambardella ML, Mallardi M et al. <article-title>Behavioral profile in RASopathies</article-title>. <source/>Am J Med Genet A
<year>2014</year>; <volume>164A</volume>: <fpage>934</fpage>–942.<pub-id pub-id-type="pmid">24458522</pub-id></mixed-citation>
</ref>
<ref id="bib122">
<mixed-citation publication-type="journal">Du M, Yuan T, Schilter KF, Dittmar RL, Mackinnon A, Huang X et al. <article-title>Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions
with multiple genomic loci across the genome</article-title>. <source/>Hum Mol Genet
<year>2014</year>; <volume>24</volume>: <fpage>154</fpage>–166.<pub-id pub-id-type="pmid">25149474</pub-id></mixed-citation>
</ref>
<ref id="bib123">
<mixed-citation publication-type="journal">Balikova I, Lehesjoki AE, de Ravel TJ, Thienpont B, Chandler KE, Clayton-Smith J et al. <article-title>Deletions in the VPS13B (COH1) gene as a cause of Cohen syndrome</article-title>. <source/>Hum Mutat
<year>2009</year>; <volume>30</volume>: <fpage>E845</fpage>–E854.<pub-id pub-id-type="pmid">19533689</pub-id></mixed-citation>
</ref>
<ref id="bib124">
<mixed-citation publication-type="journal">Mahjoub MR, Stearns T. <article-title>Supernumerary centrosomes nucleate extra cilia and compromise primary cilium
signaling</article-title>. <source/>Curr Biol
<year>2012</year>; <volume>22</volume>: <fpage>1628</fpage>–1634.<pub-id pub-id-type="pmid">22840514</pub-id></mixed-citation>
</ref>
<ref id="bib125">
<mixed-citation publication-type="journal">Bartsch O, Labonte J, Albrecht B, Wieczorek D, Lechno S, Zechner U et al. <article-title>Two patients with EP300 mutations and facial dysmorphism different from the
classic Rubinstein-Taybi syndrome</article-title>. <source/>Am J Med Genet A
<year>2010</year>; <volume>152A</volume>: <fpage>181</fpage>–184.<pub-id pub-id-type="pmid">20014264</pub-id></mixed-citation>
</ref>
<ref id="bib126">
<mixed-citation publication-type="journal">Gavrilov AA, Gushchanskaya ES, Strelkova O, Zhironkina O, Kireev II, Iarovaia OV et al. <article-title>Disclosure of a structural milieu for the proximity ligation reveals the elusive
nature of an active chromatin hub</article-title>. <source/>Nucleic Acids Res
<year>2013</year>; <volume>41</volume>: <fpage>3563</fpage>–3575.<pub-id pub-id-type="pmid">23396278</pub-id></mixed-citation>
</ref>
<ref id="bib127">
<mixed-citation publication-type="journal">Edelman LB, Fraser P. <article-title>Transcription factories: genetic programming in three dimensions</article-title>. <source/>Curr Opin Genet Dev
<year>2012</year>; <volume>22</volume>: <fpage>110</fpage>–114.<pub-id pub-id-type="pmid">22365496</pub-id></mixed-citation>
</ref>
<ref id="bib128">
<mixed-citation publication-type="journal">Park SK, Xiang Y, Feng X, Garrard WT. <article-title>Pronounced cohabitation of active immunoglobulin genes from three different
chromosomes in transcription factories during maximal antibody synthesis</article-title>. <source/>Genes Dev
<year>2014</year>; <volume>28</volume>: <fpage>1159</fpage>–1164.<pub-id pub-id-type="pmid">24888587</pub-id></mixed-citation>
</ref>
<ref id="bib129">
<mixed-citation publication-type="journal">Mitchell AC, Bharadwaj R, Whittle C, Krueger W, Mirnics K, Hurd Y et al. <article-title>The genome in three dimensions: a new frontier in human brain research</article-title>. <source/>Biol Psychiatry
<year>2014</year>; <volume>75</volume>: <fpage>961</fpage>–969.<pub-id pub-id-type="pmid">23958183</pub-id></mixed-citation>
</ref>
</ref-list>
<sec id="sup1" sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="xob1">
<label>Supplementary Figures</label>
<media xlink:href="mp201684x1.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="xob2">
<label>Supplementary Tables S1–S12</label>
<media xlink:href="mp201684x2.xlsx" xmlns:xlink="http://www.w3.org/1999/xlink">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="xob3">
<label>Supplementary Tables S13–S37</label>
<media xlink:href="mp201684x3.xlsx" xmlns:xlink="http://www.w3.org/1999/xlink">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</back>
<floats-group>
<fig id="fig1">
<label>Figure 1</label>
<caption>
<p>The 16p11.2 region and its 4C interactions profile (panels from top to bottom).
<italic>Transcripts:</italic> The transcripts mapping within the human chromosome 16
GRCh37/hg19 27–31 Mb region are indicated. The 4C-targeted
<italic>SH2B1, LAT, MVP, KCTD13, ALDOA, TBX6</italic> and <italic>MAPK3</italic> genes are
highlighted in red. <italic>Segmental duplications/viewpoints:</italic> The duplicated
regions containing the low-copy repeats (LCR) that flank these rearrangements
telomerically and centromerically are shown, whereas the position of the
restrictions fragments used as viewpoints are marked with red ticks.
<italic>CNVs:</italic> The position of the 600 kb BP4-BP5 (orange) and
220 kb BP2-BP3 intervals (blue) are depicted. <italic>Brain/LCLs:</italic> The
mean <italic>z</italic>-score for transcript expression per group (Brain or LCLs) from
GTEx is displayed. The corresponding RNA-seq heatmap color legend is showed at the
bottom left corner. <italic>PC/BRICKs:</italic> Smoothed and profile-corrected 4C
signal (upper part of each panel) and BRICKs (lower part) identified for each of
the seven 4C viewpoints within the 16p11.2 cytoband, that is, from top to bottom
<italic>SH2B1, LAT, MVP, KCTD13, ALDOA, TBX6</italic> and <italic>MAPK3</italic>. The
corresponding BRICKs significance heatmap color legend is showed at the bottom
right corner.</p>
</caption>
<graphic xlink:href="mp201684f1" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<fig id="fig2">
<label>Figure 2</label>
<caption>
<p>Phenotypic characterization of carriers of 16p11.2 BP2-BP3 and 2p15
rearrangements. Distribution of <italic>Z</italic>-score values of BMI (<bold>a</bold>) and head
circumference (<bold>b</bold>) in unrelated carriers of the 16p11.2 220 kb
BP2-BP3 deletion (red) and duplication (blue) taking into account the normal
effect of age and gender observed in the general population as described in
Jacquemont <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib18">18</xref></sup> The general
population has a mean of zero. (<bold>c</bold>) Comparison of the genomic breakpoints of
2p15 deletions (red bars) and duplications (blue bars) in 26 and 9 unrelated
carriers, respectively. The breakpoints’ coordinates are detailed in
<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>. The genes mapping
within the interval and cytobands’ positions are shown above, while the
extent of the critical region is indicated by a black bar. Distribution of
<italic>Z</italic>-score values of BMI (<bold>d</bold>) and head circumference (<bold>e</bold>) in
carriers of the 2p15 deletion (red) and duplication (blue).</p>
</caption>
<graphic xlink:href="mp201684f2" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<fig id="fig3">
<label>Figure 3</label>
<caption>
<p>Chromatin interactions between the 16p11.2 600 kb BP4-BP5 and 220 kb
BP2-BP3 genomic intervals. (<bold>a</bold>) Circos plot representation of the chromatin
loops identified in the human chromosome 16 27.5–31.0 Mb window. The
220 kb BP2-BP3 and 600 kb BP4-BP5 intervals are depicted by blue and
orange bars on the peripheral circle, respectively. Darker sections indicated the
positions of the viewpoints. Central blue and orange lines indicate the chromatin
interactions corresponding to BP2-BP3 and BP4-BP5 viewpoints, respectively. Note
the quasi absence of loops between the BP2-BP3 viewpoints (<italic>LAT</italic> and
<italic>SH2B1</italic>) and the 27.5-28.4 Mb region. The mapping position of the
<italic>KIAA0556</italic> gene, used as control locus in fluorescence <italic>in situ</italic>
hybridization experiments, is indicated. (<bold>b</bold>) High-resolution Hi-C
chromosome conformation capture results obtained in reference<sup><xref ref-type="bibr" rid="bib75">75</xref></sup> with the GM12878 LCL within the chromosome 16
0–34 Mb window (left panels) and zoom in within the
28–31 Mb region encompassing the two CNVs (5 kb resolution;
right panels). The positions of the 220 kb BP2-BP3 and 600 kb
BP4-BP5 intervals are shown by blue and orange bars, respectively. Observed (top
panel), observed/expected (central panel) and Pearson correlation results are
presented (bottom panel). (<bold>c</bold>) Fluorescence <italic>in situ</italic> hybridization
experiments show colocalization of <italic>SH2B1</italic> foci (green) that map to the
220 kb BP2-BP3 interval with <italic>ALDOA</italic> foci (red) that map to the
600 kb BP4-BP5 genomic interval (left panel) but not with the equidistant
<italic>KIAA0556</italic> (red) foci (central panel). The distribution of interphase
nuclei distances between the <italic>SH2B1</italic> and <italic>ALDOA</italic> (deep pink) and
<italic>SH2B1</italic> and <italic>KIAA0556</italic> foci (gray) are shown in the lower panel.
The mapping positions of <italic>ALDOA</italic>, <italic>SH2B1</italic> and <italic>KIAA0556</italic> are
indicated in (<bold>a</bold>)<bold>.</bold></p>
</caption>
<graphic xlink:href="mp201684f3" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<fig id="fig4">
<label>Figure 4</label>
<caption>
<p>Extensive overlap between differentially expressed genes and loci that show
modified chromatin interactions. (<bold>a</bold>) Top panel: weighted Venn diagram
showing the overlap between the 2209 genes that are differentially expressed in
16p11.2 rearrangement carriers (DE, yellow disk; FDR⩽5%<sup><xref ref-type="bibr" rid="bib12">12</xref></sup>), the 1193 genes that show modified chromatin
interactions in 16p11.2 rearrangement carriers (4C-modified, purple disk; only 665
with detectable expression are considered for the DE enrichment; see <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S31</xref>) and the 604 genes listed in
SFARI Gene (<ext-link ext-link-type="uri" xlink:href="https://sfari.org/" xmlns:xlink="http://www.w3.org/1999/xlink">https://sfari.org/</ext-link>; 323 expressed), an annotated list of candidate
genes for ASD (ASD; blue disk). The numbers of common genes are indicated and the
12 4C-modified, DE and ASD-SFARI genes are specified on the right. Bottom panels:
weighted Venn diagrams showing the overlap between the DE genes and the
LCLs-expressed ASD and 4C-modified genes (lower left and right, respectively).
(<bold>b</bold>) Circos plot representation of the modified chromatin loops
identified in human chromosomes 16 and 22 (right-hand panel). The 220 kb
BP2-BP3 and 600 kb BP4-BP5 intervals are depicted by blue and orange bars
on the peripheral circle, respectively. Central blue and orange lines indicate the
CNVs-modified chromatin interactions corresponding to BP2-BP3 and BP4-BP5
viewpoints, respectively. Ticks on the three internal rings indicate BRICKS with
significantly modified interactions between 16p11.2 600 kb BP4-BP5
duplication and control samples (light blue ring), between 16p11.2 600 kb
BP4-BP5 deletion and control samples (dark gray), and between 16p11.2
600 kb BP4-BP5 deletion and duplication samples (yellow). Blue and red
ticks on the most external rings denote genes differentially expressed in 16p11.2
patients (DE) and SFARI-ASD-associated genes (ASD), respectively. A zoomed-in view
with examples of genes with modified chromatin interactions mapping within the
22q13 cytoband is presented in the left-hand panel. (<bold>c</bold>) The 1193 genes that
show modified chromatin interaction in 16p11.2 cells with 16p11.2 600 kb
BP4-BP5 rearrangements encode proteins that interact. The confidence view
interaction network of the encoded proteins corresponding to the enriched GO terms
(GO:0030030 cell projection organization, GO:0042995 cell projection, GO:0030173
integral to Golgi membrane, GO:0000138 Golgi trans cisterna, GO:0034504 protein
localization to nucleus and GO:0005874 microtubule) is visualized with STRING.
Proteins belonging to cell projection (blue), microtubule (red), Golgi apparatus
(green), stereocilium bundle (purple) and cilium (yellow) process/cell
components are highlighted by colored beads. Disconnected nodes are not shown.
FDR, false discovery rate.</p>
</caption>
<graphic xlink:href="mp201684f4" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<fig id="fig5">
<label>Figure 5</label>
<caption>
<p>Examples of 16p11.2 viewpoints chromatin-contacted regions. (<bold>a</bold>) Examples of
regions (BRICKS) interacting with 16p11.2 viewpoints showing some of the contacted
genes, that is, <italic>GRID1</italic>, <italic>PTEN</italic> and <italic>USP34/XPO1</italic>. Other
examples (<italic>CHD1L</italic> and <italic>EP300</italic>) are shown in <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S8</xref>). Fluorescence <italic>in situ</italic>
hybridization experiments show colocalization of the 600 kb BP4-BP5
interval-encompassed <italic>KCTD13</italic> (red) and 2p15-mapping <italic>XPO1</italic> foci
(green) (<bold>b</bold>) and the 600 kb BP4-BP5 interval-encompassed <italic>MVP</italic>
(red) and 10q23.31-mapping <italic>PTEN</italic> foci (green) (<bold>d</bold>). The distribution
of interphase nuclei distances between <italic>KCTD13</italic> and <italic>XPO1</italic>
(<bold>c</bold>) and between <italic>MVP</italic> and <italic>PTEN</italic> (<bold>e</bold>) foci are compared
with to those between <italic>KCTD13/MVP</italic> and <italic>MARK4</italic> (control) foci
(25 and 14% co-localization versus 2% with the control locus;
Fisher’s test enrichment: <italic>P</italic>=6.9e<sup>−05</sup> and
<italic>P</italic>=0.01, respectively; median
<italic>MVP/KCTD13-USP34/XPO1</italic> distances=1.76,
<italic>MVP/KCTD13-PTEN</italic>=2.61 and
<italic>MVP/KCTD13-MARK4</italic>=4.96 μm; Wilcoxon rank-sum test,
<italic>P</italic>=5.4e<sup>−10</sup> and
<italic>P</italic>=9.3e<sup>−05</sup>, respectively).</p>
</caption>
<graphic xlink:href="mp201684f5" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>